메뉴 건너뛰기




Volumn 11, Issue 11, 2015, Pages 1859-1898

Recent developments in active tumor targeted multifunctional nanoparticles for combination chemotherapy in cancer treatment and imaging

Author keywords

Cancer; Combination Chemotherapy; Drug Delivery; Multi Drug Resistance; Multifunctional Nanoparticles; Nanoparticles; Targeted Nanoparticles

Indexed keywords

CHEMOTHERAPY; DISEASES; DRUG DELIVERY; DRUG DOSAGE; DRUG INTERACTIONS; DRUG THERAPY; ONCOLOGY; TUMORS;

EID: 84956577740     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2015.2145     Document Type: Review
Times cited : (115)

References (293)
  • 1
    • 0000631893 scopus 로고
    • Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope
    • A. Bangham and R. Horne, Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope. J. Mol. Biol. 8, 660 (1964).
    • (1964) J. Mol. Biol. , vol.8 , pp. 660
    • Bangham, A.1    Horne, R.2
  • 3
    • 51049090204 scopus 로고    scopus 로고
    • Nanoparticle therapeutics: An emerging treatment modality for cancer
    • M. Davis, Z. Chen, and D. Shin, Nanoparticle therapeutics: An emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7, 771 (2008).
    • (2008) Nat. Rev. Drug Discov. , vol.7 , pp. 771
    • Davis, M.1    Chen, Z.2    Shin, D.3
  • 5
    • 0031861021 scopus 로고    scopus 로고
    • Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial
    • D. W. Northfelt, B. J. Dezube, J. A. Thommes, B. J. Miller, M. A. Fischl, A. Friedman-Kien, L. D. Kaplan, C. Du Mond, R. D. Mamelok, and D. H. Henry, Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial. J. Clin. Oncol. 16, 2445 (1998).
    • (1998) J. Clin. Oncol. , vol.16 , pp. 2445
    • Northfelt, D.W.1    Dezube, B.J.2    Thommes, J.A.3    Miller, B.J.4    Fischl, M.A.5    Friedman-Kien, A.6    Kaplan, L.D.7    Du Mond, C.8    Mamelok, R.D.9    Henry, D.H.10
  • 6
    • 32944466762 scopus 로고    scopus 로고
    • Nanoparticle albumin-bound paclitaxel for metastatic breast cancer
    • M. Harries, P. Ellis, and P. Harper, Nanoparticle albumin-bound paclitaxel for metastatic breast cancer. J. Clin. Oncol. 23, 7768 (2005).
    • (2005) J. Clin. Oncol. , vol.23 , pp. 7768
    • Harries, M.1    Ellis, P.2    Harper, P.3
  • 9
    • 0022858683 scopus 로고
    • A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
    • Y. Matsumura and H. Maeda, A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46, 6387 (1986).
    • (1986) Cancer Res. , vol.46 , pp. 6387
    • Matsumura, Y.1    Maeda, H.2
  • 10
    • 70349978292 scopus 로고    scopus 로고
    • Combination therapy: Opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines
    • F. Greco and M. J. Vicent, Combination therapy: Opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. Adv. Drug Deliver. Rev. 61, 1203 (2009).
    • (2009) Adv. Drug Deliver. Rev. , vol.61 , pp. 1203
    • Greco, F.1    Vicent, M.J.2
  • 11
    • 33144488630 scopus 로고    scopus 로고
    • Prevalent mutations in prostate cancer
    • J. T. Dong, Prevalent mutations in prostate cancer. J. Cell. Biochem. 97, 433 (2006).
    • (2006) J. Cell. Biochem. , vol.97 , pp. 433
    • Dong, J.T.1
  • 12
    • 0034614637 scopus 로고    scopus 로고
    • The Hallmarks of cancer
    • D. Hanahan and R. A. Weinberg, The Hallmarks of cancer. Cell 100, 57 (2000).
    • (2000) Cell , vol.100 , pp. 57
    • Hanahan, D.1    Weinberg, R.A.2
  • 13
    • 12944312687 scopus 로고    scopus 로고
    • 50 years of preclinical anticancer drug screening: Empirical to target-driven approaches
    • M. Suggitt and M. C. Bibby, 50 years of preclinical anticancer drug screening: Empirical to target-driven approaches. Clin. Cancer Res. 11, 971 (2005).
    • (2005) Clin. Cancer Res. , vol.11 , pp. 971
    • Suggitt, M.1    Bibby, M.C.2
  • 15
    • 77954302022 scopus 로고    scopus 로고
    • Combinatorial drug conjugation enables nanoparticle dual-drug delivery
    • S. Aryal, C. M. Hu, and L. Zhang, Combinatorial drug conjugation enables nanoparticle dual-drug delivery. Small 6, 1442 (2010).
    • (2010) Small , vol.6 , pp. 1442
    • Aryal, S.1    Hu, C.M.2    Zhang, L.3
  • 17
    • 0031555233 scopus 로고    scopus 로고
    • FDA approves new kind of lymphoma treatment. Food and Drug Administration
    • J. S. James and G. Dubs, FDA approves new kind of lymphoma treatment. Food and Drug Administration. AIDS Treat. News 2 (1997).
    • (1997) AIDS Treat. News , pp. 2
    • James, J.S.1    Dubs, G.2
  • 18
    • 0033368153 scopus 로고    scopus 로고
    • Trastuzumab, a humanized anti-HER2 monoclonal antibody, for the treatment of breast cancer
    • J. Albanell and J. Baselga, Trastuzumab, a humanized anti-HER2 monoclonal antibody, for the treatment of breast cancer. Drug Today 35, 931 (1999).
    • (1999) Drug Today , vol.35 , pp. 931
    • Albanell, J.1    Baselga, J.2
  • 20
    • 38549180565 scopus 로고    scopus 로고
    • Biologically active core/shell nanopaticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier
    • L. H. Liu, K. Guo, J. Lu, S. S. Venkatraman, D. Luo, K. C. Ng, E. A. Ling, S. Moochhala, and Y. Y. Yang, Biologically active core/shell nanopaticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. Bioma-terials 10, 1509 (2008).
    • (2008) Bioma-terials , vol.10 , pp. 1509
    • Liu, L.H.1    Guo, K.2    Lu, J.3    Venkatraman, S.S.4    Luo, D.5    Ng, K.C.6    Ling, E.A.7    Moochhala, S.8    Yang, Y.Y.9
  • 21
    • 67349247858 scopus 로고    scopus 로고
    • HPMA-based polymer conjugates with drug combination
    • H. Krakovicova, T. Etrych, and K. Ulbrich, HPMA-based polymer conjugates with drug combination. Eur. J. Pharm. Sci. 37, 405 (2009).
    • (2009) Eur. J. Pharm. Sci. , vol.37 , pp. 405
    • Krakovicova, H.1    Etrych, T.2    Ulbrich, K.3
  • 22
    • 70350404331 scopus 로고    scopus 로고
    • Exploring dendrimer towards dual drug delivery: PH responsive simultaneous drug-release kinetics
    • R. K. Tekade, T. Dutta, V. Gajbhiye, and N. K. Jain, Exploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics. J. Microencapsul. 26, 287 (2009).
    • (2009) J. Microencapsul. , vol.26 , pp. 287
    • Tekade, R.K.1    Dutta, T.2    Gajbhiye, V.3    Jain, N.K.4
  • 23
    • 67249106291 scopus 로고    scopus 로고
    • Coadministration of paclitaxel and cur-cumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells
    • S. Ganta and M. Amiji, Coadministration of paclitaxel and cur-cumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol. Pharm. 6, 928 (2009).
    • (2009) Mol. Pharm. , vol.6 , pp. 928
    • Ganta, S.1    Amiji, M.2
  • 24
    • 73349141177 scopus 로고    scopus 로고
    • Co-delivery of doxorubicin and Bcl-2 siRNA by meso-porous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells
    • A. Chen, M. Zhang, D. Wei, D. Stueber, O. Taratula, T. Minko, and H. He, Co-delivery of doxorubicin and Bcl-2 siRNA by meso-porous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. Small 5, 2673 (2009).
    • (2009) Small , vol.5 , pp. 2673
    • Chen, A.1    Zhang, M.2    Wei, D.3    Stueber, D.4    Taratula, O.5    Minko, T.6    He, H.7
  • 25
    • 34548759797 scopus 로고    scopus 로고
    • Optimizing combination chemotherapy by controlling drug ratios
    • L. D. Mayer and A. S. Janoff, Optimizing combination chemotherapy by controlling drug ratios. Mol. Interv. 7, 216 (2007).
    • (2007) Mol. Interv. , vol.7 , pp. 216
    • Mayer, L.D.1    Janoff, A.S.2
  • 26
    • 33749983751 scopus 로고    scopus 로고
    • Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer
    • Y. Wang, S. Gao, W. H. Ye, H. S. Yoon, and Y. Y. Yang, Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer. Nat. Mater. 5, 791 (2006).
    • (2006) Nat. Mater. , vol.5 , pp. 791
    • Wang, Y.1    Gao, S.2    Ye, W.H.3    Yoon, H.S.4    Yang, Y.Y.5
  • 27
    • 57149142257 scopus 로고    scopus 로고
    • Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer
    • M. Saad, O. B. Garbuzenko, and T. Minko, Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer. Nanomedicine-UK. 3, 761 (2008).
    • (2008) Nanomedicine-UK. , vol.3 , pp. 761
    • Saad, M.1    Garbuzenko, O.B.2    Minko, T.3
  • 28
    • 54049117119 scopus 로고    scopus 로고
    • Molecular imaging with nanoparticles: Giant roles for dwarf actors
    • P. Debbage and W. Jaschke, Molecular imaging with nanoparticles: Giant roles for dwarf actors. Histochem. Cell Biol. 130, 845 (2008).
    • (2008) Histochem. Cell Biol. , vol.130 , pp. 845
    • Debbage, P.1    Jaschke, W.2
  • 32
    • 46749132642 scopus 로고    scopus 로고
    • Multifunctional magnetic nanoparticles for targeted imaging and therapy
    • J. R. McCarthy and R. Weissleder, Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv. Drug Deliver. Rev. 60, 1241 (2008).
    • (2008) Adv. Drug Deliver. Rev. , vol.60 , pp. 1241
    • McCarthy, J.R.1    Weissleder, R.2
  • 37
    • 84905669380 scopus 로고    scopus 로고
    • Fluorescent carbon dots for bioimaging and biosensing applications
    • H. T. Shi, J. F. Wei, L. Qiang, X. Chen, and X. W. Meng, Fluorescent carbon dots for bioimaging and biosensing applications. J. Biomed. Nanotechnol. 10, 2677 (2014).
    • (2014) J. Biomed. Nanotechnol. , vol.10 , pp. 2677
    • Shi, H.T.1    Wei, J.F.2    Qiang, L.3    Chen, X.4    Meng, X.W.5
  • 39
    • 84905641332 scopus 로고    scopus 로고
    • Applications of gold nanoparticles in optical biosensors
    • L. B. Nie, F. H. Liu, P. Ma, and X. Y. Xiao, Applications of gold nanoparticles in optical biosensors. J. Biomed. Nanotechnol. 10, 2700 (2014).
    • (2014) J. Biomed. Nanotechnol. , vol.10 , pp. 2700
    • Nie, L.B.1    Liu, F.H.2    Ma, P.3    Xiao, X.Y.4
  • 42
    • 79958189858 scopus 로고    scopus 로고
    • Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
    • A. Shapira, Y. D. Livney, H. J. Broxterman, and Y. G. Assaraf, Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance. Drug Resist. Update 14, 150 (2011).
    • (2011) Drug Resist. Update , vol.14 , pp. 150
    • Shapira, A.1    Livney, Y.D.2    Broxterman, H.J.3    Assaraf, Y.G.4
  • 43
    • 74249095292 scopus 로고    scopus 로고
    • Lipid-based nanoparticulate systems for the delivery of anti-cancer drug cocktails: Implications on pharmacokinetics and drug toxicities
    • G. N. Chiu, M. Y. Wong, L. U. Ling, I. M. Shaikh, K. B. Tan, A. Chaudhury, and B. J. Tan, Lipid-based nanoparticulate systems for the delivery of anti-cancer drug cocktails: Implications on pharmacokinetics and drug toxicities. Curr. Drug Metab. 10, 861 (2009).
    • (2009) Curr. Drug Metab. , vol.10 , pp. 861
    • Chiu, G.N.1    Wong, M.Y.2    Ling, L.U.3    Shaikh, I.M.4    Tan, K.B.5    Chaudhury, A.6    Tan, B.J.7
  • 44
    • 0036176510 scopus 로고    scopus 로고
    • Mechanisms of cancer drug resistance
    • M. M. Gottesman, Mechanisms of cancer drug resistance. Annu. Rev. Med. 53, 615 (2002).
    • (2002) Annu. Rev. Med. , vol.53 , pp. 615
    • Gottesman, M.M.1
  • 45
    • 0031815720 scopus 로고    scopus 로고
    • Size of IgG-opsonized particles determines macrophage response during internalization
    • M. Koval, K. Preiter, C. Adles, P. D. Stahl, and T. H. Steinberg, Size of IgG-opsonized particles determines macrophage response during internalization. Exp. Cell Res. 242, 265 (1998).
    • (1998) Exp. Cell Res. , vol.242 , pp. 265
    • Koval, M.1    Preiter, K.2    Adles, C.3    Stahl, P.D.4    Steinberg, T.H.5
  • 47
    • 1642575957 scopus 로고    scopus 로고
    • Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis
    • J. Rejman, V. Oberle, I. S. Zuhorn, and D. Hoekstra, Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem. J. 377, 159 (2004).
    • (2004) Biochem. J. , vol.377 , pp. 159
    • Rejman, J.1    Oberle, V.2    Zuhorn, I.S.3    Hoekstra, D.4
  • 48
    • 68349139356 scopus 로고    scopus 로고
    • Gender differences in p-glycoprotein expression and function: Effects on drug disposition and outcome
    • M. Bebawy and M. Chetty, Gender differences in p-glycoprotein expression and function: Effects on drug disposition and outcome. Curr. Drug Metab. 10, 322 (2009).
    • (2009) Curr. Drug Metab. , vol.10 , pp. 322
    • Bebawy, M.1    Chetty, M.2
  • 49
    • 0031764330 scopus 로고    scopus 로고
    • Clinical relevance of transmem-brane drug efflux as a mechanism of multidrug resistance
    • D. M. Bradshaw and R. J. Arceci, Clinical relevance of transmem-brane drug efflux as a mechanism of multidrug resistance. J. Clin. Oncol. 16, 3674 (1998).
    • (1998) J. Clin. Oncol. , vol.16 , pp. 3674
    • Bradshaw, D.M.1    Arceci, R.J.2
  • 50
    • 33846215616 scopus 로고    scopus 로고
    • A primer on the mechanics of P-glycoprotein the multidrug transporter
    • M. Hennessy and J. P. Spiers, A primer on the mechanics of P-glycoprotein the multidrug transporter. Pharmacol. Rev. 55, 1 (2007).
    • (2007) Pharmacol. Rev. , vol.55 , pp. 1
    • Hennessy, M.1    Spiers, J.P.2
  • 51
    • 0000815056 scopus 로고    scopus 로고
    • The design, fabrication and electronic properties of self-assembled molecular nanostructures
    • edited by H. S. Nalwa, American Press, San Diego, CA
    • R. P. Andres, S. Datta, D. B. Janes, C. P. Kubiak, and R. Reifenberger, The design, fabrication and electronic properties of self-assembled molecular nanostructures, Handbook of Nanos-tructured Materials and Nanotechnology, edited by H. S. Nalwa, American Press, San Diego, CA (2000), Vol. 3, pp. 179-231.
    • (2000) Handbook of Nanos-tructured Materials and Nanotechnology , vol.3 , pp. 179-231
    • Andres, R.P.1    Datta, S.2    Janes, D.B.3    Kubiak, C.P.4    Reifenberger, R.5
  • 53
    • 84957094343 scopus 로고    scopus 로고
    • edited by H. S. Nalwa, American Scientific Publisher, Los Angeles
    • W. Zhou, Encyclopedia of Nanoscience and Nanotechnology, edited by H. S. Nalwa, American Scientific Publisher, Los Angeles (2004/2011), Vol. 10, pp. 149-160.
    • (2004) Encyclopedia of Nanoscience and Nanotechnology , vol.10 , pp. 149-160
    • Zhou, W.1
  • 55
    • 19644367656 scopus 로고    scopus 로고
    • edited by H. S. Nalwa, American Scientific Publisher, Los Angeles
    • P. Walde, Encyclopedia of Nanoscience and Nanotechnology, edited by H. S. Nalwa, American Scientific Publisher, Los Angeles (2004/2011), Vol. 9, pp. 43-80.
    • (2004) Encyclopedia of Nanoscience and Nanotechnology , vol.9 , pp. 43-80
    • Walde, P.1
  • 56
    • 84904911071 scopus 로고    scopus 로고
    • A special issue on revCieowpsyrinighnat:noAmmedeicriincea, drug delivery and vaccine development
    • H. S. Nalwa, A special issue on revCieowpsyrinighnat:noAmmedeicriincea, drug delivery and vaccine development. J. Biomed. Nanotechnol. 10, 1635 (2014).
    • (2014) J. Biomed. Nanotechnol. , vol.10 , pp. 1635
    • Nalwa, H.S.1
  • 57
    • 84905642939 scopus 로고    scopus 로고
    • A special issue on reviews in biomedical applications of nanomaterials, tissue engineering, stem cells, bioimaging, and toxicity
    • H. S. Nalwa, A special issue on reviews in biomedical applications of nanomaterials, tissue engineering, stem cells, bioimaging, and toxicity. J. Biomed. Nanotechnol. 10, 2421 (2014).
    • (2014) J. Biomed. Nanotechnol. , vol.10 , pp. 2421
    • Nalwa, H.S.1
  • 58
    • 85012373035 scopus 로고
    • Diffusion of univalent ions across the lamellae of swollen phospholipids
    • A. D. Bangham, M. M. Standish, and J. C. Watkins, Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 13, 238 (1965).
    • (1965) J. Mol. Biol. , vol.13 , pp. 238
    • Bangham, A.D.1    Standish, M.M.2    Watkins, J.C.3
  • 59
    • 67650178791 scopus 로고    scopus 로고
    • Pharmacokinetics of CPX-351 (cytarabine/daunorubicin HCl) liposome injection in the mouse
    • W. F. Bayne, L. D. Mayer, and C. E. Swenson, Pharmacokinetics of CPX-351 (cytarabine/daunorubicin HCl) liposome injection in the mouse. J. Pharm. Sci. 98, 2540 (2009).
    • (2009) J. Pharm. Sci. , vol.98 , pp. 2540
    • Bayne, W.F.1    Mayer, L.D.2    Swenson, C.E.3
  • 61
    • 0032927941 scopus 로고    scopus 로고
    • Cancer multidrug resistance
    • A. Persidis, Cancer multidrug resistance. Nat. Biotechnol. 17, 94 (1999).
    • (1999) Nat. Biotechnol. , vol.17 , pp. 94
    • Persidis, A.1
  • 62
    • 0029086552 scopus 로고
    • Peripheral neurotoxicity of taxol in patients previously treated with cisplatin
    • A. Anand and M. Huberman, Peripheral neurotoxicity of taxol in patients previously treated with cisplatin. Cancer 76, 916 (1995).
    • (1995) Cancer , vol.76 , pp. 916
    • Anand, A.1    Huberman, M.2
  • 63
    • 84865480687 scopus 로고    scopus 로고
    • Nanotechnology-based combinational drug delivery: An emerging approach for cancer therapy
    • P. Parhi, C. Mohanty, and S. K. Sahoo, Nanotechnology-based combinational drug delivery: An emerging approach for cancer therapy. Drug Discov. Today 17, 1044 (2012).
    • (2012) Drug Discov. Today , vol.17 , pp. 1044
    • Parhi, P.1    Mohanty, C.2    Sahoo, S.K.3
  • 64
    • 80053977936 scopus 로고    scopus 로고
    • Resistance to chemotherapy and molecu-larly targeted therapies: Rationale for combination therapy in malignant melanoma
    • S. Wu and R. K. Singh, Resistance to chemotherapy and molecu-larly targeted therapies: Rationale for combination therapy in malignant melanoma. Curr. Mol. Med. 11, 553 (2011).
    • (2011) Curr. Mol. Med. , vol.11 , pp. 553
    • Wu, S.1    Singh, R.K.2
  • 65
    • 77956269093 scopus 로고    scopus 로고
    • Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy
    • Y. Chen, X. Zhu, X. Zhang, B. Liu, and L. Huang, Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. Mol. Ther. 18, 1650 (2010).
    • (2010) Mol. Ther. , vol.18 , pp. 1650
    • Chen, Y.1    Zhu, X.2    Zhang, X.3    Liu, B.4    Huang, L.5
  • 66
    • 58549114916 scopus 로고    scopus 로고
    • MiR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells
    • N. Li, H. Fu, Y. Tie, Z. Hu, W. Kong, Y. Wu, and X. Zheng, miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett. 275, 44 (2009).
    • (2009) Cancer Lett. , vol.275 , pp. 44
    • Li, N.1    Fu, H.2    Tie, Y.3    Hu, Z.4    Kong, W.5    Wu, Y.6    Zheng, X.7
  • 67
    • 33748098986 scopus 로고    scopus 로고
    • Targeting c-Myc, Ras and IGF cascade to treat cancer and vascular disorders
    • F. de Nigris, M. L. Balestrieri, and C. Napoli, Targeting c-Myc, Ras and IGF cascade to treat cancer and vascular disorders. Cell Cycle 5, 1621 (2006).
    • (2006) Cell Cycle , vol.5 , pp. 1621
    • De Nigris, F.1    Balestrieri, M.L.2    Napoli, C.3
  • 68
    • 34247610328 scopus 로고    scopus 로고
    • P53 translational control: A new facet of p53 regulation and its implication for tumorigenesis and cancer therapeutics
    • M. J. Halaby and D. Q. Yang, p53 translational control: A new facet of p53 regulation and its implication for tumorigenesis and cancer therapeutics. Genetics 395, 1 (2007).
    • (2007) Genetics , vol.395 , pp. 1
    • Halaby, M.J.1    Yang, D.Q.2
  • 69
    • 33750375191 scopus 로고    scopus 로고
    • Future directions in vascular endothelial growth factor-targeted therapy for metastatic colorectal cancer
    • A. Grothey, Future directions in vascular endothelial growth factor-targeted therapy for metastatic colorectal cancer. Semin. Oncol. 33, S41 (2006).
    • (2006) Semin. Oncol. , vol.33 , pp. S41
    • Grothey, A.1
  • 70
    • 83555173191 scopus 로고    scopus 로고
    • Cationic liposomal co-delivery of small interfering RNA and a MEK inhibitor for enhanced anticancer efficacy
    • S. H. Kang, H. J. Cho, G. Shim, S. Lee, S. H. Kim, H. G. Choi, C. W. Kim, and Y. K. Oh, Cationic liposomal co-delivery of small interfering RNA and a MEK inhibitor for enhanced anticancer efficacy. Pharm. Res. 28, 3069 (2011).
    • (2011) Pharm. Res. , vol.28 , pp. 3069
    • Kang, S.H.1    Cho, H.J.2    Shim, G.3    Lee, S.4    Kim, S.H.5    Choi, H.G.6    Kim, C.W.7    Oh, Y.K.8
  • 73
    • 84863164382 scopus 로고    scopus 로고
    • Two-in-one: Combined targeted chemo and gene therapy for tumor suppression and prevention of metas-tases
    • M. Zhang, O. B. Garbuzenko, K. R. Reuhl, L. Rodriguez-Rodriguez, and T. Minko, Two-in-one: Combined targeted chemo and gene therapy for tumor suppression and prevention of metas-tases. Nanomedicine-UK. 7, 185 (2012).
    • (2012) Nanomedicine-UK. , vol.7 , pp. 185
    • Zhang, M.1    Garbuzenko, O.B.2    Reuhl, K.R.3    Rodriguez-Rodriguez, L.4    Minko, T.5
  • 74
    • 77954534436 scopus 로고    scopus 로고
    • Palmitoyl ascorbate-modified liposomes as nanoparticle platform for ascorbate-mediated cytotoxicity and paclitaxel co-delivery
    • R. R. Sawant, O. S. Vaze, K. Rockwell, and V. P. Torchilin, Palmitoyl ascorbate-modified liposomes as nanoparticle platform for ascorbate-mediated cytotoxicity and paclitaxel co-delivery. Eur. J. Pharm. Biopharm. 75, 321 (2010).
    • (2010) Eur. J. Pharm. Biopharm. , vol.75 , pp. 321
    • Sawant, R.R.1    Vaze, O.S.2    Rockwell, K.3    Torchilin, V.P.4
  • 75
    • 77954534436 scopus 로고    scopus 로고
    • Palmitoyl ascorbate-modified liposomes as nanoparticle platform for ascorbate-mediated cytotoxicity and paclitaxel co-delivery
    • R. R. Sawant, O. S. Vaze, K. Rockwell, and V. P. Torchilin, Palmitoyl ascorbate-modified liposomes as nanoparticle platform for ascorbate-mediated cytotoxicity and paclitaxel co-delivery. Eur. J. Pharm. Biopharm. 75, 321 (2010).
    • (2010) Eur. J. Pharm. Biopharm. , vol.75 , pp. 321
    • Sawant, R.R.1    Vaze, O.S.2    Rockwell, K.3    Torchilin, V.P.4
  • 78
    • 81155127751 scopus 로고    scopus 로고
    • First-in-human phase i study of Atu027, a liposomal small interfering RNA formulation, targeting protein kinase N3 (PKN3) in patients with advanced solid tumors
    • D. Strumberg, B. Schultheis, U. Traugott, C. Vank, A. Santel, O. Keil, K. Giese, J. Kaufmann, and J. Drevs, First-in-human phase I study of Atu027, a liposomal small interfering RNA formulation, targeting protein kinase N3 (PKN3) in patients with advanced solid tumors. J. Clin. Oncol. 29, 1 (2011).
    • (2011) J. Clin. Oncol. , vol.29 , pp. 1
    • Strumberg, D.1    Schultheis, B.2    Traugott, U.3    Vank, C.4    Santel, A.5    Keil, O.6    Giese, K.7    Kaufmann, J.8    Drevs, J.9
  • 79
    • 84866728365 scopus 로고    scopus 로고
    • Spatiotemporally controlled co-delivery of anti-vasculature agent and cytotoxic drug by octreotide-modified stealth liposomes
    • W. Dai, W. Jin, J. Zhang, X. Wang, J. Wang, X. Zhang, Y. Wan, and Q. Zhang, Spatiotemporally controlled co-delivery of anti-vasculature agent and cytotoxic drug by octreotide-modified stealth liposomes. Pharm. Res. 29, 2902 (2012).
    • (2012) Pharm. Res. , vol.29 , pp. 2902
    • Dai, W.1    Jin, W.2    Zhang, J.3    Wang, X.4    Wang, J.5    Zhang, X.6    Wan, Y.7    Zhang, Q.8
  • 80
    • 61849134849 scopus 로고    scopus 로고
    • Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity
    • J. Hu, L. J. Chen, L. Liu, X. Chen, P. L. Chen, G. Yang, W. L. Hou, M. H. Tang, F. Zhang, X. H. Wang, X. Zhao, and Y. Q. Wei, Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity. Exp. Mol. Med. 40, 617 (2008).
    • (2008) Exp. Mol. Med. , vol.40 , pp. 617
    • Hu, J.1    Chen, L.J.2    Liu, L.3    Chen, X.4    Chen, P.L.5    Yang, G.6    Hou, W.L.7    Tang, M.H.8    Zhang, F.9    Wang, X.H.10    Zhao, X.11    Wei, Y.Q.12
  • 82
    • 84868340593 scopus 로고    scopus 로고
    • A combination of liposomal suni-tinib plus liposomal irinotecan and liposome co-loaded with two drugs enhanced antitumor activity in PC12-bearing mouse
    • Y. Maitani, H. Saito, Y. Seishi, Y. Iwase, T. Yamauchi, K. Higashiyama, and T. Sugino, A combination of liposomal suni-tinib plus liposomal irinotecan and liposome co-loaded with two drugs enhanced antitumor activity in PC12-bearing mouse. J. Drug Target. 20, 873 (2012).
    • (2012) J. Drug Target. , vol.20 , pp. 873
    • Maitani, Y.1    Saito, H.2    Seishi, Y.3    Iwase, Y.4    Yamauchi, T.5    Higashiyama, K.6    Sugino, T.7
  • 83
  • 84
    • 77649185057 scopus 로고    scopus 로고
    • Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: In vitro and in vivo studies
    • Y. F. Zhang, J. C. Wang, D. Y. Bian, X. Zhang, and Q. Zhang, Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: In vitro and in vivo studies. Eur. J. Pharm. Biopharm. 74, 467 (2010).
    • (2010) Eur. J. Pharm. Biopharm. , vol.74 , pp. 467
    • Zhang, Y.F.1    Wang, J.C.2    Bian, D.Y.3    Zhang, X.4    Zhang, Q.5
  • 85
    • 84861691386 scopus 로고    scopus 로고
    • Characterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: Relating structure and pharmacokinetics to therapeutic efficacy
    • D. Zucker, A. V. Andriyanov, A. Steiner, U. Raviv, and Y. Barenholz, Characterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: Relating structure and pharmacokinetics to therapeutic efficacy. J. Control Release. 160, 281 (2012).
    • (2012) J. Control Release. , vol.160 , pp. 281
    • Zucker, D.1    Andriyanov, A.V.2    Steiner, A.3    Raviv, U.4    Barenholz, Y.5
  • 86
    • 82255193872 scopus 로고    scopus 로고
    • Liposome formulation of co-encapsulated vincristine and quercetin enhanced antitumor activity in a trastuzumab-insensitive breast tumor xenograft model
    • M. Y. Wong and G. N. Chiu, Liposome formulation of co-encapsulated vincristine and quercetin enhanced antitumor activity in a trastuzumab-insensitive breast tumor xenograft model. Nanomedicine-UK. 7, 834 (2011).
    • (2011) Nanomedicine-UK. , vol.7 , pp. 834
    • Wong, M.Y.1    Chiu, G.N.2
  • 87
    • 84865154500 scopus 로고    scopus 로고
    • Pharmacokinetics of CPX-351; A nano-scale liposomal fixed molar ratio formulation of cytarabine: Daunorubicin, in patients with advanced leukemia
    • E. J. Feldman, J. E. Kolitz, J. M. Trang, B. D. Liboiron, C. E. Swenson, M. T. Chiarella, L. D. Mayer, A. C. Louie, and J. E. Lancet, Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine: Daunorubicin, in patients with advanced leukemia. Leukemia Res. 36, 1283 (2012).
    • (2012) Leukemia Res. , vol.36 , pp. 1283
    • Feldman, E.J.1    Kolitz, J.E.2    Trang, J.M.3    Liboiron, B.D.4    Swenson, C.E.5    Chiarella, M.T.6    Mayer, L.D.7    Louie, A.C.8    Lancet, J.E.9
  • 88
    • 77955280642 scopus 로고    scopus 로고
    • Leukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine: Daunorubicin formulation, in bone marrow xenografts
    • W. S. Lim, P. G. Tardi, N. Dos Santos, X. Xie, M. Fan, B. D. Liboiron, X. Huang, T. O. Harasym, D. Bermudes, and L. D. Mayer, Leukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine: Daunorubicin formulation, in bone marrow xenografts. Leukemia Res. 34, 1214 (2010).
    • (2010) Leukemia Res. , vol.34 , pp. 1214
    • Lim, W.S.1    Tardi, P.G.2    Dos Santos, N.3    Xie, X.4    Fan, M.5    Liboiron, B.D.6    Huang, X.7    Harasym, T.O.8    Bermudes, D.9    Mayer, L.D.10
  • 89
    • 79960919311 scopus 로고    scopus 로고
    • Anti-tumor activity of liposome encapsulated fluoroorotic acid as a single agent and in combination with liposome irinotecan
    • K. Riviere, H. M. Kieler-Ferguson, K. Jerger, and F. C. Szoka, Jr., Anti-tumor activity of liposome encapsulated fluoroorotic acid as a single agent and in combination with liposome irinotecan. J. Control Release 153, 288 (2011).
    • (2011) J. Control Release , vol.153 , pp. 288
    • Riviere, K.1    Kieler-Ferguson, H.M.2    Jerger, K.3    Szoka, F.C.4
  • 91
    • 67249139762 scopus 로고    scopus 로고
    • Cationic liposomes loaded with proapoptotic peptide D-(KLAKLAK)(2) and Bcl-2 antisense oligodeoxynucleotide G3139 for enhanced anticancer therapy
    • Y. T. Ko, C. Falcao, and V. P. Torchilin, Cationic liposomes loaded with proapoptotic peptide D-(KLAKLAK)(2) and Bcl-2 antisense oligodeoxynucleotide G3139 for enhanced anticancer therapy. Mol. Pharm. 6, 971 (2009).
    • (2009) Mol. Pharm. , vol.6 , pp. 971
    • Ko, Y.T.1    Falcao, C.2    Torchilin, V.P.3
  • 92
    • 84868089602 scopus 로고    scopus 로고
    • Co-delivery of doxorubicin and PSC 833 (Valspodar) by stealth nanoliposomes for efficient overcoming of multidrug resistance
    • E. Bajelan, A. Haeri, A. M. Vali, S. N. Ostad, and S. Dadashzadeh, Co-delivery of doxorubicin and PSC 833 (Valspodar) by stealth nanoliposomes for efficient overcoming of multidrug resistance. J. Pharm. Pharm. Sci. 15, 568 (2012).
    • (2012) J. Pharm. Pharm. Sci. , vol.15 , pp. 568
    • Bajelan, E.1    Haeri, A.2    Vali, A.M.3    Ostad, S.N.4    Dadashzadeh, S.5
  • 93
    • 84904871589 scopus 로고    scopus 로고
    • Photodynamic therapy: One step ahead with self-assembled nanoparticles
    • P. Avci, S. S. Erdem, and M. R. Hamblin, Photodynamic therapy: One step ahead with self-assembled nanoparticles. J. Biomed. Nanotechnol. 10, 1937 (2014).
    • (2014) J. Biomed. Nanotechnol. , vol.10 , pp. 1937
    • Avci, P.1    Erdem, S.S.2    Hamblin, M.R.3
  • 94
    • 84865450664 scopus 로고    scopus 로고
    • In vitro evaluation of combined hyperther-mia and photodynamic effects using magnetoliposomes loaded with cucurbituril zinc phthalocyanine complex on melanoma
    • G. C. Bolfarini, M. P. Siqueira-Moura, G. J. Demets, P. C. Morais, and A. C. Tedesco, In vitro evaluation of combined hyperther-mia and photodynamic effects using magnetoliposomes loaded with cucurbituril zinc phthalocyanine complex on melanoma. J. Photoch. Photobio. B. 115, 1 (2012).
    • (2012) J. Photoch. Photobio. B. , vol.115 , pp. 1
    • Bolfarini, G.C.1    Siqueira-Moura, M.P.2    Demets, G.J.3    Morais, P.C.4    Tedesco, A.C.5
  • 95
    • 1242337285 scopus 로고    scopus 로고
    • Solubilizing excipients in oral and injectable formulations
    • R. G. Strickley, Solubilizing excipients in oral and injectable formulations. Pharm. Res. 21, 201 (2004).
    • (2004) Pharm. Res. , vol.21 , pp. 201
    • Strickley, R.G.1
  • 97
    • 0029398545 scopus 로고
    • Water-soluble block polycations as carriers for oligonucleotide delivery
    • A. Kabanov, S. Vinogradov, Y. Suzdaltseva, and A. Vyu, Water-soluble block polycations as carriers for oligonucleotide delivery. Bioconjugate Chem. 6, 639 (1995).
    • (1995) Bioconjugate Chem. , vol.6 , pp. 639
    • Kabanov, A.1    Vinogradov, S.2    Suzdaltseva, Y.3    Vyu, A.4
  • 98
    • 84862830732 scopus 로고    scopus 로고
    • Nanoparticle-based combination therapy toward overcoming drug resistance in cancer
    • C. M. Hu and L. Zhang, Nanoparticle-based combination therapy toward overcoming drug resistance in cancer. Biochem. Pharmacol. 83, 1104 (2012).
    • (2012) Biochem. Pharmacol. , vol.83 , pp. 1104
    • Hu, C.M.1    Zhang, L.2
  • 99
    • 33845388144 scopus 로고    scopus 로고
    • Micellar nanocarriers: Pharmaceutical perspectives
    • V. P. Torchilin, Micellar nanocarriers: Pharmaceutical perspectives. Pharm. Res. 24, 1 (2007).
    • (2007) Pharm. Res. , vol.24 , pp. 1
    • Torchilin, V.P.1
  • 100
    • 76249115138 scopus 로고    scopus 로고
    • Degradation and degradation-induced re-assembly of PVP-PCL micelles
    • Y. Hu, Z. Jiang, R. Chen, W. Wu, and X. Jiang, Degradation and degradation-induced re-assembly of PVP-PCL micelles. Biomacro-molecules 11, 481 (2010).
    • (2010) Biomacro-molecules , vol.11 , pp. 481
    • Hu, Y.1    Jiang, Z.2    Chen, R.3    Wu, W.4    Jiang, X.5
  • 102
    • 79952767984 scopus 로고    scopus 로고
    • Reconstitutable charged polymeric (PLGA)(2)-b-PEI micelles for gene therapeutics delivery
    • D. Mishra, H. C. Kang, and Y. H. Bae, Reconstitutable charged polymeric (PLGA)(2)-b-PEI micelles for gene therapeutics delivery. Biomaterials 32, 3845 (2011).
    • (2011) Biomaterials , vol.32 , pp. 3845
    • Mishra, D.1    Kang, H.C.2    Bae, Y.H.3
  • 104
    • 77952740852 scopus 로고    scopus 로고
    • Design and evaluation of micellar nanocarriers for 17-allyamino-17-demethoxygeldanamycin (17-AAG)
    • T. Chandran, U. Katragadda, Q. Teng, and C. Tan, Design and evaluation of micellar nanocarriers for 17-allyamino-17-demethoxygeldanamycin (17-AAG). Int. J. Pharm. 392, 170 (2010).
    • (2010) Int. J. Pharm. , vol.392 , pp. 170
    • Chandran, T.1    Katragadda, U.2    Teng, Q.3    Tan, C.4
  • 105
    • 0035850224 scopus 로고    scopus 로고
    • Structure and design of polymeric surfactant-based drug delivery systems
    • V. P. Torchilin, Structure and design of polymeric surfactant-based drug delivery systems. J. Control Release 73, 137 (2001).
    • (2001) J. Control Release , vol.73 , pp. 137
    • Torchilin, V.P.1
  • 106
    • 0037151313 scopus 로고    scopus 로고
    • Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery
    • A. V. Kabanov, E. V. Batrakova, and V. Y Alakhov, Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J. Control Release 82, 189 (2002).
    • (2002) J. Control Release , vol.82 , pp. 189
    • Kabanov, A.V.1    Batrakova, E.V.2    Alakhov, V.Y.3
  • 107
    • 77952208384 scopus 로고    scopus 로고
    • Poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles containing chemically conjugated and physically entrapped docetaxel: Synthesis, characterization, and the influence of the drug on micelle morphology
    • A. S. Mikhail and C. Allen, Poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles containing chemically conjugated and physically entrapped docetaxel: Synthesis, characterization, and the influence of the drug on micelle morphology. Biomacromolecules 11, 1273 (2010).
    • (2010) Biomacromolecules , vol.11 , pp. 1273
    • Mikhail, A.S.1    Allen, C.2
  • 108
    • 2942548218 scopus 로고    scopus 로고
    • Block copolymer-coated calcium phosphate nanoparticles sensing intracellular environment for oligodeoxynucleotide and siRNA delivery
    • Y. Kakizawa, S. Furukawa, and K. Kataoka, Block copolymer-coated calcium phosphate nanoparticles sensing intracellular environment for oligodeoxynucleotide and siRNA delivery. J. Control Release 97, 345 (2004).
    • (2004) J. Control Release , vol.97 , pp. 345
    • Kakizawa, Y.1    Furukawa, S.2    Kataoka, K.3
  • 109
    • 0037148656 scopus 로고    scopus 로고
    • Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery
    • A. Lavasanifar, J. Samuel, and G. S. Kwon, Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery. Adv. Drug Deliver. Rev. 54, 169 (2002).
    • (2002) Adv. Drug Deliver. Rev. , vol.54 , pp. 169
    • Lavasanifar, A.1    Samuel, J.2    Kwon, G.S.3
  • 110
    • 41249099944 scopus 로고    scopus 로고
    • New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting
    • P. Chytil, T. Etrych, C. Konak, M. Sirova, T. Mrkvan, J. Boucek, B. Rihova, and K. Ulbrich, New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting. J. Control Release 127, 121 (2008).
    • (2008) J. Control Release , vol.127 , pp. 121
    • Chytil, P.1    Etrych, T.2    Konak, C.3    Sirova, M.4    Mrkvan, T.5    Boucek, J.6    Rihova, B.7    Ulbrich, K.8
  • 111
    • 57049128257 scopus 로고    scopus 로고
    • One-pot conversion of RAFT-generated multifunctional block copolymers of HPMA to doxorubicin conjugated acid-and reductant-sensitive crosslinked micelles
    • Z. Jia, L. Wong, T. P. Davis, and V. Bulmus, One-pot conversion of RAFT-generated multifunctional block copolymers of HPMA to doxorubicin conjugated acid-and reductant-sensitive crosslinked micelles. Biomacromolecules 9, 3106 (2008).
    • (2008) Biomacromolecules , vol.9 , pp. 3106
    • Jia, Z.1    Wong, L.2    Davis, T.P.3    Bulmus, V.4
  • 112
    • 36749064493 scopus 로고    scopus 로고
    • A prostate-specific antigen activated N-(2-hydroxypropyl) methacrylamide copolymer prodrug as dual-targeted therapy for prostate cancer
    • S. S. Chandran, A. Nan, D. M. Rosen, H. Ghandehari, and S. R. Denmeade, A prostate-specific antigen activated N-(2-hydroxypropyl) methacrylamide copolymer prodrug as dual-targeted therapy for prostate cancer. Mol. Cancer Ther 6, 2928 (2007).
    • (2007) Mol. Cancer Ther , vol.6 , pp. 2928
    • Chandran, S.S.1    Nan, A.2    Rosen, D.M.3    Ghandehari, H.4    Denmeade, S.R.5
  • 113
    • 0037072339 scopus 로고    scopus 로고
    • Synthesis and micellar characterization of novel amphiphilic A-B-A triblock copolymers of N-(2-Hydroxypropyl)methacrylamide or N-Vinyl-2-pyrrolidone with Poly(s-caprolactone)
    • B. S. Lele and J. C. Leroux, Synthesis and micellar characterization of novel amphiphilic A-B-A triblock copolymers of N-(2-Hydroxypropyl)methacrylamide or N-Vinyl-2-pyrrolidone with Poly(s-caprolactone). Macromolecules 35, 6714 (2002).
    • (2002) Macromolecules , vol.35 , pp. 6714
    • Lele, B.S.1    Leroux, J.C.2
  • 117
    • 79961065218 scopus 로고    scopus 로고
    • Synthesis and characterization of poly(epsilon-caprolactone)-block-poly[N-(2-hydroxypropyl)methacrylamide] micelles for drug delivery
    • S. G. Krimmer, H. Pan, J. Liu, J. Yang, and J. Kopecek, Synthesis and characterization of poly(epsilon-caprolactone)-block-poly[N-(2-hydroxypropyl)methacrylamide] micelles for drug delivery. Macromol. Biosci. 11, 1041 (2011).
    • (2011) Macromol. Biosci. , vol.11 , pp. 1041
    • Krimmer, S.G.1    Pan, H.2    Liu, J.3    Yang, J.4    Kopecek, J.5
  • 118
    • 57649124218 scopus 로고    scopus 로고
    • The co-delivery of paclitaxel and herceptin using cationic micellar nanoparticles
    • A. L. Lee, Y. Wang, H. Y. Cheng, S. Pervaiz, and Y. Y. Yang, The co-delivery of paclitaxel and herceptin using cationic micellar nanoparticles. Biomaterials 30, 919 (2009).
    • (2009) Biomaterials , vol.30 , pp. 919
    • Lee, A.L.1    Wang, Y.2    Cheng, H.Y.3    Pervaiz, S.4    Yang, Y.Y.5
  • 119
    • 78651279520 scopus 로고    scopus 로고
    • Polymeric micelles in anticancer therapy: Targeting, imaging and triggered release
    • C. Oerlemans, W. Bult, M. Bos, G. Storm, J. F. Nijsen, and W. E. Hennink, Polymeric micelles in anticancer therapy: Targeting, imaging and triggered release. Pharm. Res. 27, 2569 (2010).
    • (2010) Pharm. Res. , vol.27 , pp. 2569
    • Oerlemans, C.1    Bult, W.2    Bos, M.3    Storm, G.4    Nijsen, J.F.5    Hennink, W.E.6
  • 121
    • 84891373113 scopus 로고    scopus 로고
    • Co-delivery of chemotherapeutic drugs with Vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance
    • H. Zhu, H. Chen, X. Zeng, Z. Wang, X. Zhang, Y. Wu, Y. Gao, J. Zhang, K. Liu, R. Liu, L. Cai, L. Mei, and S.-S. Feng, Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance. Biomaterials 35, 2391 (2014).
    • (2014) Biomaterials , vol.35 , pp. 2391
    • Zhu, H.1    Chen, H.2    Zeng, X.3    Wang, Z.4    Zhang, X.5    Wu, Y.6    Gao, Y.7    Zhang, J.8    Liu, K.9    Liu, R.10    Cai, L.11    Mei, L.12    Feng, S.-S.13
  • 122
    • 80052386569 scopus 로고    scopus 로고
    • Enhanced anti-tumor efficacy by co-delivery of doxoru-bicin and paclitaxel with amphiphilic methoxy PEG-PLGA copoly-mer nanoparticles
    • H. Wang, Y. Zhao, Y. Wu, Y.-l. Hu, K. Nan, G. Nie, and H. Chen, Enhanced anti-tumor efficacy by co-delivery of doxoru-bicin and paclitaxel with amphiphilic methoxy PEG-PLGA copoly-mer nanoparticles. Biomaterials 32, 8281 (2011).
    • (2011) Biomaterials , vol.32 , pp. 8281
    • Wang, H.1    Zhao, Y.2    Wu, Y.3    Hu, Y.-L.4    Nan, K.5    Nie, G.6    Chen, H.7
  • 124
    • 84874941640 scopus 로고    scopus 로고
    • Nanoparti-cle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse model
    • A. Roy, M. S. Singh, P. Upadhyay, and S. Bhaskar, Nanoparti-cle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse model. Int. J. Pharm. 445, 171 (2013).
    • (2013) Int. J. Pharm. , vol.445 , pp. 171
    • Roy, A.1    Singh, M.S.2    Upadhyay, P.3    Bhaskar, S.4
  • 125
    • 84887017263 scopus 로고    scopus 로고
    • Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery
    • X. Ma, Y. Zhao, K. W. Ng, and Y. Zhao, Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery. Chem-Eur. J. 19, 15593 (2013).
    • (2013) Chem-Eur. J. , vol.19 , pp. 15593
    • Ma, X.1    Zhao, Y.2    Ng, K.W.3    Zhao, Y.4
  • 126
    • 84874443644 scopus 로고    scopus 로고
    • Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo
    • H. Meng, W. Mai, H. Zhang, M. Xue, T. Xia, S. Lin, X. Wang, Y. Zhao, Z. Ji, J. Zink, and A. Nel, Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. ACS 7, 994 (2013).
    • (2013) ACS , vol.7 , pp. 994
    • Meng, H.1    Mai, W.2    Zhang, H.3    Xue, M.4    Xia, T.5    Lin, S.6    Wang, X.7    Zhao, Y.8    Ji, Z.9    Zink, J.10    Nel, A.11
  • 127
    • 84904087632 scopus 로고    scopus 로고
    • Shape-mediated biological effects of mesoporous silica nanoparticles
    • N. J. Hao, L. F. Li, and F. Q. Tang, Shape-mediated biological effects of mesoporous silica nanoparticles. J. Biomed. Nanotechnol. 10, 2508 (2014).
    • (2014) J. Biomed. Nanotechnol. , vol.10 , pp. 2508
    • Hao, N.J.1    Li, L.F.2    Tang, F.Q.3
  • 128
  • 129
    • 79953054576 scopus 로고    scopus 로고
    • The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
    • J. Fang, H. Nakamura, and H. Maeda, The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv. Drug Deliver. Rev. 63, 136 (2011).
    • (2011) Adv. Drug Deliver. Rev. , vol.63 , pp. 136
    • Fang, J.1    Nakamura, H.2    Maeda, H.3
  • 130
    • 79958842169 scopus 로고    scopus 로고
    • Alpha-amino acid containing degradable polymers as functional biomaterials: Rational design, synthetic pathway, and biomedical applications
    • H. Sun, F. Meng, A. A. Dias, M. Hendriks, J. Feijen, and Z. Zhong, Alpha-amino acid containing degradable polymers as functional biomaterials: Rational design, synthetic pathway, and biomedical applications. Biomacromolecules 12, 1937 (2011).
    • (2011) Biomacromolecules , vol.12 , pp. 1937
    • Sun, H.1    Meng, F.2    Dias, A.A.3    Hendriks, M.4    Feijen, J.5    Zhong, Z.6
  • 131
    • 77954249976 scopus 로고    scopus 로고
    • Polymeric drug delivery systems for localized cancer chemotherapy
    • R. De Souza, P. Zahedi, C. J. Allen, and M. Piquette-Miller, Polymeric drug delivery systems for localized cancer chemotherapy. Drug Deliver. 17, 365 (2010).
    • (2010) Drug Deliver. , vol.17 , pp. 365
    • De Souza, R.1    Zahedi, P.2    Allen, C.J.3    Piquette-Miller, M.4
  • 133
    • 84858260797 scopus 로고    scopus 로고
    • Physicochemical properties and biocompatibility of a polymer-paclitaxel conjugate for cancer treatment
    • D. Yang, S. Van, J. Liu, J. Wang, X. Jiang, Y. Wang, and L. Yu, Physicochemical properties and biocompatibility of a polymer-paclitaxel conjugate for cancer treatment. Intl. J. Nanomed. 6, 2557 (2011).
    • (2011) Intl. J. Nanomed. , vol.6 , pp. 2557
    • Yang, D.1    Van, S.2    Liu, J.3    Wang, J.4    Jiang, X.5    Wang, Y.6    Yu, L.7
  • 134
    • 10744219907 scopus 로고    scopus 로고
    • A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity
    • J. M. Metselaar, P. Bruin, L. W. de Boer, T. de Vringer, C. Snel, C. Oussoren, M. H. Wauben, D. J. Crommelin, G. Storm, and W. E. Hennink, A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity. Bioconjugate Chem. 14, 1156 (2003).
    • (2003) Bioconjugate Chem. , vol.14 , pp. 1156
    • Metselaar, J.M.1    Bruin, P.2    De Boer, L.W.3    De Vringer, T.4    Snel, C.5    Oussoren, C.6    Wauben, M.H.7    Crommelin, D.J.8    Storm, G.9    Hennink, W.E.10
  • 135
    • 77950350157 scopus 로고    scopus 로고
    • Polysaccharide-modified synthetic polymeric biomaterials
    • A. D. Baldwin and K. L. Kiick, Polysaccharide-modified synthetic polymeric biomaterials. Biopolymers 94, 128 (2010).
    • (2010) Biopolymers , vol.94 , pp. 128
    • Baldwin, A.D.1    Kiick, K.L.2
  • 136
    • 0029132960 scopus 로고
    • Inhibition of lymphoma growth in vivo by combined treatment with hydroxyethyl starch deferoxam-ine conjugate and IgG monoclonal antibodies against the transferrin receptor
    • J. D. Kemp, T. Cardillo, B. C. Stewart, E. Kehrberg, G. Weiner, B. Hedlund, and P. W. Naumann, Inhibition of lymphoma growth in vivo by combined treatment with hydroxyethyl starch deferoxam-ine conjugate and IgG monoclonal antibodies against the transferrin receptor. Cancer Res. 55, 3817 (1995).
    • (1995) Cancer Res. , vol.55 , pp. 3817
    • Kemp, J.D.1    Cardillo, T.2    Stewart, B.C.3    Kehrberg, E.4    Weiner, G.5    Hedlund, B.6    Naumann, P.W.7
  • 138
    • 70349984537 scopus 로고    scopus 로고
    • XMT-1001, a novel polymeric camptothecin pro-drug in clinical development for patients with advanced cancer
    • A. V. Yurkovetskiy and R. J. Fram, XMT-1001, a novel polymeric camptothecin pro-drug in clinical development for patients with advanced cancer. Adv. Drug Deliver. Rev. 61, 1193 (2009).
    • (2009) Adv. Drug Deliver. Rev. , vol.61 , pp. 1193
    • Yurkovetskiy, A.V.1    Fram, R.J.2
  • 139
    • 34548626932 scopus 로고    scopus 로고
    • Biological and clinical characterization of paclitaxel poliglumex (PPX, CT-2103), a macromolecular polymer-drug conjugate
    • S. D. Chipman, F. B. Oldham, G. Pezzoni, and J. W. Singer, Biological and clinical characterization of paclitaxel poliglumex (PPX, CT-2103), a macromolecular polymer-drug conjugate. Intl. J. Nanomed. 1, 375 (2006).
    • (2006) Intl. J. Nanomed. , vol.1 , pp. 375
    • Chipman, S.D.1    Oldham, F.B.2    Pezzoni, G.3    Singer, J.W.4
  • 140
    • 77949412572 scopus 로고    scopus 로고
    • A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate cancer after docetaxel chemotherapy
    • T. M. Beer, C. Ryan, J. Alumkal, C. W. Ryan, J. Sun, and K. M. Eilers, A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate cancer after docetaxel chemotherapy. Colloq. Inse. 21, 433 (2010).
    • (2010) Colloq. Inse. , vol.21 , pp. 433
    • Beer, T.M.1    Ryan, C.2    Alumkal, J.3    Ryan, C.W.4    Sun, J.5    Eilers, K.M.6
  • 142
    • 56749178680 scopus 로고    scopus 로고
    • A phase II trial of paclitaxel poliglumex in recurrent or persistent ovarian or primary peritoneal cancer (EOC): A gynecologic oncology group study
    • P. Sabbatini, M. W. Sill, D. O'Malley, L. Adler, A. A. Secord, and S. Gynecologic Oncology Group, A phase II trial of paclitaxel poliglumex in recurrent or persistent ovarian or primary peritoneal cancer (EOC): A gynecologic oncology group study. Gynecol. Oncol. 111, 455 (2008).
    • (2008) Gynecol. Oncol. , vol.111 , pp. 455
    • Sabbatini, P.1    Sill, M.W.2    O'Malley, D.3    Adler, L.4    Secord, A.A.5
  • 144
    • 24644433861 scopus 로고    scopus 로고
    • Paclitaxel poliglumex. Cell Therapeu-tics/Chugai Pharmaceutical
    • M. Man and H. Rugo, Paclitaxel poliglumex. Cell Therapeu-tics/Chugai Pharmaceutical. IDrugs. 8, 739 (2005).
    • (2005) IDrugs. , vol.8 , pp. 739
    • Man, M.1    Rugo, H.2
  • 145
    • 41549105038 scopus 로고    scopus 로고
    • Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory model
    • P. Sapra, H. Zhao, M. Mehlig, J. Malaby, P. Kraft, C. Longley, L. M. Greenberger, and I. D. Horak, Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory model. Clin. Cancer Res. 14, 1888 (2008).
    • (2008) Clin. Cancer Res. , vol.14 , pp. 1888
    • Sapra, P.1    Zhao, H.2    Mehlig, M.3    Malaby, J.4    Kraft, P.5    Longley, C.6    Greenberger, L.M.7    Horak, I.D.8
  • 146
    • 0034026798 scopus 로고    scopus 로고
    • Poly(ethylene glycol) multiblock copolymer as a carrier of anti-cancer drug doxorubicin
    • M. Pechar, K. Ulbrich, V. Subr, L. W. Seymour, and E. H. Schacht, Poly(ethylene glycol) multiblock copolymer as a carrier of anti-cancer drug doxorubicin. Bioconjugate Chem. 11, 131 (2000).
    • (2000) Bioconjugate Chem. , vol.11 , pp. 131
    • Pechar, M.1    Ulbrich, K.2    Subr, V.3    Seymour, L.W.4    Schacht, E.H.5
  • 147
    • 57049169207 scopus 로고    scopus 로고
    • Conjugates of doxorubicin with graft HPMA copoly-mers for passive tumor targeting
    • T. Etrych, P. Chytil, T. Mrkvan, M. Sirova, B. Rihova, and K. Ulbrich, Conjugates of doxorubicin with graft HPMA copoly-mers for passive tumor targeting. J. Control Release 132, 184 (2008).
    • (2008) J. Control Release , vol.132 , pp. 184
    • Etrych, T.1    Chytil, P.2    Mrkvan, T.3    Sirova, M.4    Rihova, B.5    Ulbrich, K.6
  • 149
    • 80052517546 scopus 로고    scopus 로고
    • Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy
    • T. Etrych, L. Kovar, J. Strohalm, P. Chytil, B. Rihova, and K. Ulbrich, Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy. J. Control Release. 154, 241 (2011).
    • (2011) J. Control Release. , vol.154 , pp. 241
    • Etrych, T.1    Kovar, L.2    Strohalm, J.3    Chytil, P.4    Rihova, B.5    Ulbrich, K.6
  • 150
    • 79551684989 scopus 로고    scopus 로고
    • Synthesis of biodegradable multiblock copolymers by click coupling of RAFT-generated heterotelechelicpolyhpma conjugates
    • J. Yang, K. Luo, H. Pan, P. Kopeckova, and J. Kopecek, Synthesis of biodegradable multiblock copolymers by click coupling of RAFT-generated heterotelechelicpolyhpma conjugates. React. Funct. Polym. 71, 294 (2011).
    • (2011) React. Funct. Polym. , vol.71 , pp. 294
    • Yang, J.1    Luo, K.2    Pan, H.3    Kopeckova, P.4    Kopecek, J.5
  • 151
    • 79955017504 scopus 로고    scopus 로고
    • Biodegradable multiblock poly[N-(2-hydroxypropyl)methacrylamide] via reversible addition-fragmentation chain transfer polymerization and click chemistry
    • K. Luo, J. Yang, P. Kopeckova, and J. Kopecek, Biodegradable multiblock poly[N-(2-hydroxypropyl)methacrylamide] via reversible addition-fragmentation chain transfer polymerization and click chemistry. Macromolecules 44, 2481 (2011).
    • (2011) Macromolecules , vol.44 , pp. 2481
    • Luo, K.1    Yang, J.2    Kopeckova, P.3    Kopecek, J.4
  • 152
    • 84925547527 scopus 로고    scopus 로고
    • Co-delivery of oxaliplatin and demethylcantharidin via a polymer-drug conjugate
    • E. Wang, H. Xiong, D. Zhou, Z. Xie, Y. Huang, X. Jing, and X. Sun, Co-delivery of oxaliplatin and demethylcantharidin via a polymer-drug conjugate. Macromol. Biosci. 14, 588 (2014).
    • (2014) Macromol. Biosci. , vol.14 , pp. 588
    • Wang, E.1    Xiong, H.2    Zhou, D.3    Xie, Z.4    Huang, Y.5    Jing, X.6    Sun, X.7
  • 153
    • 68549109372 scopus 로고    scopus 로고
    • Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier
    • T. L. Kaneshiro and Z. R. Lu, Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier. Biomaterials 30, 5660 (2009).
    • (2009) Biomaterials , vol.30 , pp. 5660
    • Kaneshiro, T.L.1    Lu, Z.R.2
  • 156
    • 0035342007 scopus 로고    scopus 로고
    • Poly(amidoamine) (PAMAM) den-drimers: From biomimicry to drug delivery and biomedical applications
    • R. Esfand and D. A. Tomalia, Poly(amidoamine) (PAMAM) den-drimers: From biomimicry to drug delivery and biomedical applications. Drug Discover. Today 6, 427 (2001).
    • (2001) Drug Discover. Today , vol.6 , pp. 427
    • Esfand, R.1    Tomalia, D.A.2
  • 157
    • 28744443398 scopus 로고    scopus 로고
    • Dendrimers in biomedical applications-reflections on the field
    • S. Svenson and D. A. Tomalia, Dendrimers in biomedical applications-reflections on the field. Adv. Drug Deliver. Rev. 57, 2106 (2005).
    • (2005) Adv. Drug Deliver. Rev. , vol.57 , pp. 2106
    • Svenson, S.1    Tomalia, D.A.2
  • 158
    • 78549287793 scopus 로고    scopus 로고
    • PAMAM-camptothecin conjugate inhibits proliferation and induces nuclear fragmentation in colorectal carcinoma cells
    • G. Thiagarajan, A. Ray, A. Malugin, and H. Ghandehari, PAMAM-camptothecin conjugate inhibits proliferation and induces nuclear fragmentation in colorectal carcinoma cells. Pharm. Res. 27, 2307 (2010).
    • (2010) Pharm. Res. , vol.27 , pp. 2307
    • Thiagarajan, G.1    Ray, A.2    Malugin, A.3    Ghandehari, H.4
  • 159
    • 77958156329 scopus 로고    scopus 로고
    • Carboxyl-terminated PAMAM-SN38 conjugates: Synthesis, characterization, and in vitro evaluation
    • N. Vijayalakshmi, A. Ray, A. Malugin, and H. Ghandehari, Carboxyl-terminated PAMAM-SN38 conjugates: Synthesis, characterization, and in vitro evaluation. Bioconjugate Chem. 21, 1804 (2010).
    • (2010) Bioconjugate Chem. , vol.21 , pp. 1804
    • Vijayalakshmi, N.1    Ray, A.2    Malugin, A.3    Ghandehari, H.4
  • 161
    • 77949275122 scopus 로고    scopus 로고
    • Dendrimer-based drug and imaging conjugates: Design considerations for nanomedical applications
    • A. R. Menjoge, R. M. Kannan, and D. A. Tomalia, Dendrimer-based drug and imaging conjugates: Design considerations for nanomedical applications. Drug Discover. Today 15, 171 (2010).
    • (2010) Drug Discover. Today , vol.15 , pp. 171
    • Menjoge, A.R.1    Kannan, R.M.2    Tomalia, D.A.3
  • 163
    • 0037433811 scopus 로고    scopus 로고
    • A PEGylated dendritic nanoparticulate carrier of fluorouracil
    • D. Bhadra, S. Bhadra, S. Jain, and N. K. Jain, A PEGylated dendritic nanoparticulate carrier of fluorouracil. Int. J. Pharm. 257, 111 (2003).
    • (2003) Int. J. Pharm. , vol.257 , pp. 111
    • Bhadra, D.1    Bhadra, S.2    Jain, S.3    Jain, N.K.4
  • 164
    • 38349134916 scopus 로고    scopus 로고
    • Dendrimers as drug carriers: Applications in different routes of drug administration
    • Y. Cheng, Z. Xu, M. Ma, and T. Xu, Dendrimers as drug carriers: Applications in different routes of drug administration. J. Pharm. Sci. 97, 123 (2008).
    • (2008) J. Pharm. Sci. , vol.97 , pp. 123
    • Cheng, Y.1    Xu, Z.2    Ma, M.3    Xu, T.4
  • 165
    • 77955466733 scopus 로고    scopus 로고
    • Cellular entry of G3.5 poly (amido amine) dendrimers by clathrin-and dynamin-dependent endocytosis promotes tight junctional opening in intestinal epithelia
    • D. S. Goldberg, H. Ghandehari, and P. W. Swaan, Cellular entry of G3.5 poly (amido amine) dendrimers by clathrin-and dynamin-dependent endocytosis promotes tight junctional opening in intestinal epithelia. Pharm. Res. 27, 1547 (2010).
    • (2010) Pharm. Res. , vol.27 , pp. 1547
    • Goldberg, D.S.1    Ghandehari, H.2    Swaan, P.W.3
  • 166
    • 77955640333 scopus 로고    scopus 로고
    • Polymeric carriers for gene delivery: Chitosan and poly(amidoamine) dendrimers
    • Q. Xu, C. H. Wang, and D. W. Pack, Polymeric carriers for gene delivery: Chitosan and poly(amidoamine) dendrimers. Curr. Pharm. Des. 16, 2350 (2010).
    • (2010) Curr. Pharm. Des. , vol.16 , pp. 2350
    • Xu, Q.1    Wang, C.H.2    Pack, D.W.3
  • 167
    • 24944531237 scopus 로고    scopus 로고
    • Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy
    • I. J. Majoros, T. P. Thomas, C. B. Mehta, and J. R. Baker, Jr., Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy. J. Med. Chem. 48, 5892 (2005).
    • (2005) J. Med. Chem. , vol.48 , pp. 5892
    • Majoros, I.J.1    Thomas, T.P.2    Mehta, C.B.3    Baker, J.R.4
  • 169
    • 79953234437 scopus 로고    scopus 로고
    • Solubility and in vitro transder-mal diffusion of riboflavin assisted by PAMAM dendrimers
    • A. Filipowicz and S. Wolowiec, Solubility and in vitro transder-mal diffusion of riboflavin assisted by PAMAM dendrimers. Int. J. Pharm. 408, 152 (2011).
    • (2011) Int. J. Pharm. , vol.408 , pp. 152
    • Filipowicz, A.1    Wolowiec, S.2
  • 170
    • 0033800262 scopus 로고    scopus 로고
    • Anionic PAMAM dendrimers rapidly cross adult rat intestine in vitro: A potential oral delivery system?
    • R. Wiwattanapatapee, B. Carreno-Gomez, N. Malik, and R. Duncan, Anionic PAMAM dendrimers rapidly cross adult rat intestine in vitro: A potential oral delivery system?. Pharm. Res. 17, 991 (2000).
    • (2000) Pharm. Res. , vol.17 , pp. 991
    • Wiwattanapatapee, R.1    Carreno-Gomez, B.2    Malik, N.3    Duncan, R.4
  • 171
    • 84859761719 scopus 로고    scopus 로고
    • Transepithelial transport and tox-icity of PAMAM dendrimers: Implications for oral drug delivery
    • S. Sadekar and H. Ghandehari, Transepithelial transport and tox-icity of PAMAM dendrimers: Implications for oral drug delivery. Adv. Drug Deliver. Rev. 64, 571 (2012).
    • (2012) Adv. Drug Deliver. Rev. , vol.64 , pp. 571
    • Sadekar, S.1    Ghandehari, H.2
  • 173
    • 79959976472 scopus 로고    scopus 로고
    • Dendrimers as novel systems for delivery of neuropharmaceuticals to the brain
    • S. Beg, A. Samad, M. Alam, and I. Nazish, Dendrimers as novel systems for delivery of neuropharmaceuticals to the brain. CNS Neurol. Disord-Dr. 10, 576 (2011).
    • (2011) CNS Neurol. Disord-Dr. , vol.10 , pp. 576
    • Beg, S.1    Samad, A.2    Alam, M.3    Nazish, I.4
  • 174
    • 78449252867 scopus 로고    scopus 로고
    • PEGylated poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors
    • H. He, Y. Li, X. R. Jia, J. Du, X. Ying, W. L. Lu, J. N. Lou, and Y. Wei, PEGylated poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors. Biomaterials 32, 478 (2011).
    • (2011) Biomaterials , vol.32 , pp. 478
    • He, H.1    Li, Y.2    Jia, X.R.3    Du, J.4    Ying, X.5    Lu, W.L.6    Lou, J.N.7    Wei, Y.8
  • 175
    • 70350200866 scopus 로고    scopus 로고
    • Gene delivery targeted to the brain using an angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer
    • W. Ke, K. Shao, R. Huang, L. Han, Y. Liu, J. Li, Y. Kuang, L. Ye, J. Lou, and C. Jiang, Gene delivery targeted to the brain using an angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. Biomaterials 30, 6976 (2009).
    • (2009) Biomaterials , vol.30 , pp. 6976
    • Ke, W.1    Shao, K.2    Huang, R.3    Han, L.4    Liu, Y.5    Li, J.6    Kuang, Y.7    Ye, L.8    Lou, J.9    Jiang, C.10
  • 176
    • 78751580253 scopus 로고    scopus 로고
    • Peptide and glycopeptide dendrimers and analogous dendrimeric structures and their biomed-ical applications
    • J. Sebestik, P. Niederhafner, and J. Jezek, Peptide and glycopeptide dendrimers and analogous dendrimeric structures and their biomed-ical applications. Amino Acids 40, 301 (2011).
    • (2011) Amino Acids , vol.40 , pp. 301
    • Sebestik, J.1    Niederhafner, P.2    Jezek, J.3
  • 177
    • 37549044726 scopus 로고    scopus 로고
    • Design, synthesis and potent pharmaceutical applications of glycodendrimers: A mini review
    • Y. Li, Y. Cheng, and T. Xu, Design, synthesis and potent pharmaceutical applications of glycodendrimers: A mini review. Curr. Drug Discov. Technol. 4, 246 (2007).
    • (2007) Curr. Drug Discov. Technol. , vol.4 , pp. 246
    • Li, Y.1    Cheng, Y.2    Xu, T.3
  • 178
    • 0037117526 scopus 로고    scopus 로고
    • Dendrimers and supramolecular chemistry
    • J. M. Frechet, Dendrimers and supramolecular chemistry. P. Natl. Acad. Sci. USA. 99, 4782 (2002).
    • (2002) P. Natl. Acad. Sci. USA. , vol.99 , pp. 4782
    • Frechet, J.M.1
  • 179
    • 80054691692 scopus 로고    scopus 로고
    • A 5-fluorouracil-loaded pH-responsive dendrimer nanocarrier for tumor targeting
    • Y. Jin, X. Ren, W. Wang, L. Ke, E. Ning, L. Du, and J. Bradshaw, A 5-fluorouracil-loaded pH-responsive dendrimer nanocarrier for tumor targeting. Int. J. Pharm. 420, 378 (2011).
    • (2011) Int. J. Pharm. , vol.420 , pp. 378
    • Jin, Y.1    Ren, X.2    Wang, W.3    Ke, L.4    Ning, E.5    Du, L.6    Bradshaw, J.7
  • 180
    • 80053547937 scopus 로고    scopus 로고
    • Guest-release control in enzyme-sensitive, amphiphilic-dendrimerbased nanoparticles through photochemical crosslinking
    • K. R. Raghupathi, M. A. Azagarsamy, and S. Thayumanavan, Guest-release control in enzyme-sensitive, amphiphilic-dendrimerbased nanoparticles through photochemical crosslinking. Chem-Eur. J. 17, 11752 (2011).
    • (2011) Chem-Eur. J. , vol.17 , pp. 11752
    • Raghupathi, K.R.1    Azagarsamy, M.A.2    Thayumanavan, S.3
  • 182
    • 67650690627 scopus 로고    scopus 로고
    • Dendrimers as carriers for delivery of chemotherapeutic agents
    • S. H. Medina and M. E. El-Sayed, Dendrimers as carriers for delivery of chemotherapeutic agents. Chem. Rev. 109, 3141 (2009).
    • (2009) Chem. Rev. , vol.109 , pp. 3141
    • Medina, S.H.1    El-Sayed, M.E.2
  • 183
  • 184
    • 0142010620 scopus 로고    scopus 로고
    • Starlike versus classic macromolecular prodrugs: Two different antibody-targeted HPMA copolymers of doxorubicin studied in vitro and in vivo as potential anticancer drugs
    • M. Jelinkova, J. Strohalm, T. Etrych, K. Ulbrich, and B. Rihova, Starlike versus classic macromolecular prodrugs: Two different antibody-targeted HPMA copolymers of doxorubicin studied in vitro and in vivo as potential anticancer drugs. Pharm. Res. 20, 1558 (2003).
    • (2003) Pharm. Res. , vol.20 , pp. 1558
    • Jelinkova, M.1    Strohalm, J.2    Etrych, T.3    Ulbrich, K.4    Rihova, B.5
  • 185
    • 33845216424 scopus 로고    scopus 로고
    • Dendrimer versus linear conjugate: Influence of polymeric architecture on the delivery and anticancer effect of paclitaxel
    • J. J. Khandare, S. Jayant, A. Singh, P. Chandna, Y. Wang, N. Vorsa, and T. Minko, Dendrimer versus linear conjugate: Influence of polymeric architecture on the delivery and anticancer effect of paclitaxel. Bioconjugate Chem. 17, 1464 (2006).
    • (2006) Bioconjugate Chem. , vol.17 , pp. 1464
    • Khandare, J.J.1    Jayant, S.2    Singh, A.3    Chandna, P.4    Wang, Y.5    Vorsa, N.6    Minko, T.7
  • 186
    • 79954579637 scopus 로고    scopus 로고
    • Design of biocompatible dendrimers for cancer diagnosis and therapy: Current status and future perspectives
    • Y. Cheng, L. Zhao, Y. Li, and T. Xu, Design of biocompatible dendrimers for cancer diagnosis and therapy: Current status and future perspectives. Chem. Soc. Rev. 40, 2673 (2011).
    • (2011) Chem. Soc. Rev. , vol.40 , pp. 2673
    • Cheng, Y.1    Zhao, L.2    Li, Y.3    Xu, T.4
  • 187
    • 79955051898 scopus 로고    scopus 로고
    • G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity
    • D. S. Goldberg, N. Vijayalakshmi, P. W. Swaan, and H. Ghandehari, G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity. J. Control Release 150, 318 (2011).
    • (2011) J. Control Release , vol.150 , pp. 318
    • Goldberg, D.S.1    Vijayalakshmi, N.2    Swaan, P.W.3    Ghandehari, H.4
  • 188
    • 77955982005 scopus 로고    scopus 로고
    • Mechanistic studies of in vitro cytotoxicity of poly(amidoamine) dendrimers in mammalian cells
    • S. P. Mukherjee, F. M. Lyng, A. Garcia, M. Davoren, and H. J. Byrne, Mechanistic studies of in vitro cytotoxicity of poly(amidoamine) dendrimers in mammalian cells. Toxicol. Appl. Pharm. 248, 259 (2010).
    • (2010) Toxicol. Appl. Pharm. , vol.248 , pp. 259
    • Mukherjee, S.P.1    Lyng, F.M.2    Garcia, A.3    Davoren, M.4    Byrne, H.J.5
  • 191
    • 73349141177 scopus 로고    scopus 로고
    • Co-delivery of doxorubicin and Bcl-2 siRNA by meso-porous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells
    • A. M. Chen, M. Zhang, D. Wei, D. Stueber, O. Taratula, T. Minko, and H. He, Co-delivery of doxorubicin and Bcl-2 siRNA by meso-porous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. Small 5, 2673 (2009).
    • (2009) Small , vol.5 , pp. 2673
    • Chen, A.M.1    Zhang, M.2    Wei, D.3    Stueber, D.4    Taratula, O.5    Minko, T.6    He, H.7
  • 192
    • 77549083832 scopus 로고    scopus 로고
    • Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy
    • F. Dilnawaz, A. Singh, C. Mohanty, and S. K. Sahoo, Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. Biomaterials 31, 3694 (2010).
    • (2010) Biomaterials , vol.31 , pp. 3694
    • Dilnawaz, F.1    Singh, A.2    Mohanty, C.3    Sahoo, S.K.4
  • 193
    • 79955960211 scopus 로고    scopus 로고
    • Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy
    • A. Singh, F. Dilnawaz, S. Mewar, U. Sharma, N. Jagannathan, and S. Sahoo, Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy. ACS Appl. Mater. Interfaces 3, 842 (2011).
    • (2011) ACS Appl. Mater. Interfaces , vol.3 , pp. 842
    • Singh, A.1    Dilnawaz, F.2    Mewar, S.3    Sharma, U.4    Jagannathan, N.5    Sahoo, S.6
  • 194
    • 84892675615 scopus 로고    scopus 로고
    • Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA
    • O. Taratula, A. Kuzmov, M. Shah, O. B. Garbuzenko, and T. Minko, Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA. J. Control Release 171, 349 (2013).
    • (2013) J. Control Release , vol.171 , pp. 349
    • Taratula, O.1    Kuzmov, A.2    Shah, M.3    Garbuzenko, O.B.4    Minko, T.5
  • 196
    • 34848918210 scopus 로고    scopus 로고
    • Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging
    • D. W. Bartlett, H. Su, I. J. Hildebrandt, W. A. Weber, and M. E. Davis, Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. P. Natl. Acad. Sci. USA. 104, 15549 (2007).
    • (2007) P. Natl. Acad. Sci. USA. , vol.104 , pp. 15549
    • Bartlett, D.W.1    Su, H.2    Hildebrandt, I.J.3    Weber, W.A.4    Davis, M.E.5
  • 197
    • 51249122212 scopus 로고    scopus 로고
    • Does a targeting ligand influence nanoparticle tumor localization or uptake?
    • K. F. Pirollo and E. H. Chang, Does a targeting ligand influence nanoparticle tumor localization or uptake?. Trends Biotechnol. 26, 552 (2008).
    • (2008) Trends Biotechnol. , vol.26 , pp. 552
    • Pirollo, K.F.1    Chang, E.H.2
  • 198
    • 61849153021 scopus 로고    scopus 로고
    • Impact of nanotechnology on drug delivery
    • O. C. Farokhzad and R. Langer, Impact of nanotechnology on drug delivery. ACS Nano 3, 16 (2009).
    • (2009) ACS Nano , vol.3 , pp. 16
    • Farokhzad, O.C.1    Langer, R.2
  • 199
    • 70449529637 scopus 로고    scopus 로고
    • Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases
    • R. Gabathuler, Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiol. Dis. 37, 48 (2010).
    • (2010) Neurobiol. Dis. , vol.37 , pp. 48
    • Gabathuler, R.1
  • 201
    • 1642362625 scopus 로고    scopus 로고
    • Drug delivery systems: Entering the mainstream
    • T. M. Allen and P. R. Cullis, Drug delivery systems: Entering the mainstream. Science 303, 1818 (2004).
    • (2004) Science , vol.303 , pp. 1818
    • Allen, T.M.1    Cullis, P.R.2
  • 202
    • 43149123796 scopus 로고    scopus 로고
    • Impact of hapten presentation on antibody binding at lipid membrane interfaces
    • H. Jung, T. Yang, M. D. Lasagna, J. Shi, G. D. Reinhart, and P. S. Cremer, Impact of hapten presentation on antibody binding at lipid membrane interfaces. Biophys. J. 94, 3094 (2008).
    • (2008) Biophys. J. , vol.94 , pp. 3094
    • Jung, H.1    Yang, T.2    Lasagna, M.D.3    Shi, J.4    Reinhart, G.D.5    Cremer, P.S.6
  • 203
    • 84863666971 scopus 로고    scopus 로고
    • Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy
    • M. K. Yu, J. Park, and S. Jon, Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics 2, 3 (2012).
    • (2012) Theranostics , vol.2 , pp. 3
    • Yu, M.K.1    Park, J.2    Jon, S.3
  • 204
    • 27944490875 scopus 로고    scopus 로고
    • VEGF as a therapeutic target in cancer
    • N. Ferrara, VEGF as a therapeutic target in cancer. Oncology 69(Suppl 3), 11 (2005).
    • (2005) Oncology , vol.69 , pp. 11
    • Ferrara, N.1
  • 206
    • 84885172782 scopus 로고    scopus 로고
    • Targeted co-delivery of doc-etaxel, cisplatin and herceptin by Vitamin E TPGS-cisplatin pro-drug nanoparticles for multimodality treatment of cancer
    • Y. Mi, J. Zhao, and S. S. Feng, Targeted co-delivery of doc-etaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin pro-drug nanoparticles for multimodality treatment of cancer. J. Control Release 169, 185 (2013).
    • (2013) J. Control Release , vol.169 , pp. 185
    • Mi, Y.1    Zhao, J.2    Feng, S.S.3
  • 207
    • 77955388676 scopus 로고    scopus 로고
    • EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma
    • C. G. Hadjipanayis, R. Machaidze, M. Kaluzova, L. Wang, A. J. Schuette, H. Chen, X. Wu, and H. Mao, EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma. Cancer Res. 70, 6303 (2010).
    • (2010) Cancer Res. , vol.70 , pp. 6303
    • Hadjipanayis, C.G.1    Machaidze, R.2    Kaluzova, M.3    Wang, L.4    Schuette, A.J.5    Chen, H.6    Wu, X.7    Mao, H.8
  • 208
    • 3543022686 scopus 로고    scopus 로고
    • In vivo cancer targeting and imaging with semiconductor quantum dots
    • X. Gao, Y. Cui, R. M. Levenson, L. W. Chung, and S. Nie, In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 22, 969 (2004).
    • (2004) Nat. Biotechnol. , vol.22 , pp. 969
    • Gao, X.1    Cui, Y.2    Levenson, R.M.3    Chung, L.W.4    Nie, S.5
  • 211
    • 54949122951 scopus 로고    scopus 로고
    • Therapeutic efficacy of a herpes simplex virus with radiation or temo-zolomide for intracranial glioblastoma after convection-enhanced delivery
    • C. G. Hadjipanayis, W. Fellows-Mayle, and N. A. Deluca, Therapeutic efficacy of a herpes simplex virus with radiation or temo-zolomide for intracranial glioblastoma after convection-enhanced delivery. Mol. Ther. 16, 1783 (2008).
    • (2008) Mol. Ther. , vol.16 , pp. 1783
    • Hadjipanayis, C.G.1    Fellows-Mayle, W.2    Deluca, N.A.3
  • 213
    • 79960847763 scopus 로고    scopus 로고
    • Dual doc-etaxel/superparamagnetic iron oxide loaded nanoparticles for both targeting magnetic resonance imaging and cancer therapy
    • Y. Ling, K. Wei, Y. Luo, X. Gao, and S. Zhong, Dual doc-etaxel/superparamagnetic iron oxide loaded nanoparticles for both targeting magnetic resonance imaging and cancer therapy. Bioma-terials 32, 7139 (2011).
    • (2011) Bioma-terials , vol.32 , pp. 7139
    • Ling, Y.1    Wei, K.2    Luo, Y.3    Gao, X.4    Zhong, S.5
  • 215
    • 59649085079 scopus 로고    scopus 로고
    • MRI-visible polymeric vector bearing CD3 single chain antibody for gene delivery to T cells for immunosuppression
    • G. Chen, W. Chen, Z. Wu, R. Yuan, H. Li, J. Gao, and X. Shuai, MRI-visible polymeric vector bearing CD3 single chain antibody for gene delivery to T cells for immunosuppression. Biomaterials 30, 1962 (2009).
    • (2009) Biomaterials , vol.30 , pp. 1962
    • Chen, G.1    Chen, W.2    Wu, Z.3    Yuan, R.4    Li, H.5    Gao, J.6    Shuai, X.7
  • 218
    • 0037163130 scopus 로고    scopus 로고
    • Regulation of T cell receptor-induced activation of the Ras-ERK pathway by diacylglycerol kinase zeta
    • X. P. Zhong, E. A. Hainey, B. A. Olenchock, H. Zhao, M. K. Topham, and G. A. Koretzky, Regulation of T cell receptor-induced activation of the Ras-ERK pathway by diacylglycerol kinase zeta. J. Biol. Chem. 277, 31089 (2002).
    • (2002) J. Biol. Chem. , vol.277 , pp. 31089
    • Zhong, X.P.1    Hainey, E.A.2    Olenchock, B.A.3    Zhao, H.4    Topham, M.K.5    Koretzky, G.A.6
  • 219
    • 79951771952 scopus 로고    scopus 로고
    • Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery
    • R. M. Lu, Y. L. Chang, M. S. Chen, and H. C. Wu, Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery. Biomaterials 32, 3265 (2011).
    • (2011) Biomaterials , vol.32 , pp. 3265
    • Lu, R.M.1    Chang, Y.L.2    Chen, M.S.3    Wu, H.C.4
  • 222
    • 0038115223 scopus 로고    scopus 로고
    • HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro
    • S. Ding, T. Merkulova-Rainon, Z. C. Han, and G. Tobelem, HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro. Blood 101, 4816 (2003).
    • (2003) Blood , vol.101 , pp. 4816
    • Ding, S.1    Merkulova-Rainon, T.2    Han, Z.C.3    Tobelem, G.4
  • 225
    • 77957358317 scopus 로고    scopus 로고
    • Image-guided breast tumor therapy using a small interfering RNA nan-odrug
    • M. Kumar, M. Yigit, G. Dai, A. Moore, and Z. Medarova, Image-guided breast tumor therapy using a small interfering RNA nan-odrug. Cancer Res. 70, 7553 (2010).
    • (2010) Cancer Res. , vol.70 , pp. 7553
    • Kumar, M.1    Yigit, M.2    Dai, G.3    Moore, A.4    Medarova, Z.5
  • 226
    • 0026659195 scopus 로고
    • Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen
    • L. Perey, D. F. Hayes, P. Maimonis, M. Abe, C. O'Hara, and D. W. Kufe, Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen. Cancer Res. 52, 2563 (1992).
    • (1992) Cancer Res. , vol.52 , pp. 2563
    • Perey, L.1    Hayes, D.F.2    Maimonis, P.3    Abe, M.4    O'Hara, C.5    Kufe, D.W.6
  • 228
    • 84863131190 scopus 로고    scopus 로고
    • Paclitaxel/tetrandrine coloaded nanoparticles effectively promote the apoptosis of gastric cancer cells based on oxidation therapy
    • X. Li, X. Lu, H. Xu, Z. Zhu, H. Yin, X. Qian, R. Li, X. Jiang, and B. Liu, Paclitaxel/tetrandrine coloaded nanoparticles effectively promote the apoptosis of gastric cancer cells based on oxidation therapy. Mol. Pharm. 9, 222 (2012).
    • (2012) Mol. Pharm. , vol.9 , pp. 222
    • Li, X.1    Lu, X.2    Xu, H.3    Zhu, Z.4    Yin, H.5    Qian, X.6    Li, R.7    Jiang, X.8    Liu, B.9
  • 229
    • 42949138711 scopus 로고    scopus 로고
    • Enhanced intracellular delivery of quantum dot and adenovirus nanoparticles triggered by acidic pH via surface charge reversal
    • H. Mok, J. W. Park, and T. G. Park, Enhanced intracellular delivery of quantum dot and adenovirus nanoparticles triggered by acidic pH via surface charge reversal. Bioconjugate Chem. 19, 797 (2008).
    • (2008) Bioconjugate Chem. , vol.19 , pp. 797
    • Mok, H.1    Park, J.W.2    Park, T.G.3
  • 231
    • 31544441899 scopus 로고    scopus 로고
    • PH-responsive sulfon-amide/PEI system for tumor specific gene delivery: An in vitro study
    • V. A. Sethuraman, K. Na, and Y. H. Bae, pH-responsive sulfon-amide/PEI system for tumor specific gene delivery: An in vitro study. Biomacromolecules 7, 64 (2006).
    • (2006) Biomacromolecules , vol.7 , pp. 64
    • Sethuraman, V.A.1    Na, K.2    Bae, Y.H.3
  • 232
    • 78649962007 scopus 로고    scopus 로고
    • PH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells
    • H. Mok, O. Veiseh, C. Fang, F. M. Kievit, F. Y. Wang, J. O. Park, and M. Zhang, pH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells. Mol. Pharm. 7, 1930 (2010).
    • (2010) Mol. Pharm. , vol.7 , pp. 1930
    • Mok, H.1    Veiseh, O.2    Fang, C.3    Kievit, F.M.4    Wang, F.Y.5    Park, J.O.6    Zhang, M.7
  • 233
    • 34247881886 scopus 로고    scopus 로고
    • A protein nanocarrier from charge-conversion polymer in response to endosomal pH
    • Y. Lee, S. Fukushima, Y. Bae, S. Hiki, T. Ishii, and K. Kataoka, A protein nanocarrier from charge-conversion polymer in response to endosomal pH. J. Am. Chem. Soc. 129, 5362 (2007).
    • (2007) J. Am. Chem. Soc. , vol.129 , pp. 5362
    • Lee, Y.1    Fukushima, S.2    Bae, Y.3    Hiki, S.4    Ishii, T.5    Kataoka, K.6
  • 235
    • 59449102796 scopus 로고    scopus 로고
    • Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer
    • E. A. Perez, Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer. Breast Cancer Res. Tr. 114, 195 (2009).
    • (2009) Breast Cancer Res. Tr. , vol.114 , pp. 195
    • Perez, E.A.1
  • 236
    • 77249174795 scopus 로고    scopus 로고
    • Recent developments in carbohydrate-decorated targeted drug/gene delivery
    • H. Zhang, Y. Ma, and X. L. Sun, Recent developments in carbohydrate-decorated targeted drug/gene delivery. Med. Res. Rev. 30, 270 (2010).
    • (2010) Med. Res. Rev. , vol.30 , pp. 270
    • Zhang, H.1    Ma, Y.2    Sun, X.L.3
  • 238
    • 27744585027 scopus 로고    scopus 로고
    • Asialoglycoprotein receptor targeted gene delivery using galactosylated polyethylenimine-graft-poly(ethylene glycol): In vitro and in vivo studies
    • E. M. Kim, H. J. Jeong, I. K. Park, C. S. Cho, H. B. Moon, D. Y. Yu, H. S. Bom, M. H. Sohn, and I. J. Oh, Asialoglycoprotein receptor targeted gene delivery using galactosylated polyethylenimine-graft-poly(ethylene glycol): In vitro and in vivo studies. J. Control Release 108, 557 (2005).
    • (2005) J. Control Release , vol.108 , pp. 557
    • Kim, E.M.1    Jeong, H.J.2    Park, I.K.3    Cho, C.S.4    Moon, H.B.5    Yu, D.Y.6    Bom, H.S.7    Sohn, M.H.8    Oh, I.J.9
  • 239
    • 77950803130 scopus 로고    scopus 로고
    • Galactosy-lated poly(2-(2-aminoethyoxy)ethoxy)phosphazene/DNA complex nanoparticles: In vitro and in vivo evaluation for gene delivery
    • Y. Yang, Z. Zhang, L. Chen, W. Gu, and Y. Li, Galactosy-lated poly(2-(2-aminoethyoxy)ethoxy)phosphazene/DNA complex nanoparticles: In vitro and in vivo evaluation for gene delivery. Biomacromolecules 11, 927 (2010).
    • (2010) Biomacromolecules , vol.11 , pp. 927
    • Yang, Y.1    Zhang, Z.2    Chen, L.3    Gu, W.4    Li, Y.5
  • 241
    • 61349088718 scopus 로고    scopus 로고
    • Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres
    • W. Lu, C. Xiong, G. Zhang, Q. Huang, R. Zhang, J. Z. Zhang, and C. Li, Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres. Clin. Cancer Res. 15, 876 (2009).
    • (2009) Clin. Cancer Res. , vol.15 , pp. 876
    • Lu, W.1    Xiong, C.2    Zhang, G.3    Huang, Q.4    Zhang, R.5    Zhang, J.Z.6    Li, C.7
  • 242
    • 0345714785 scopus 로고    scopus 로고
    • Current perspectives on the cellular uptake and trafficking of riboflavin
    • A. B. Foraker, C. M. Khantwal, and P. W. Swaan, Current perspectives on the cellular uptake and trafficking of riboflavin. Adv. Drug Deliver. Rev. 55, 1467 (2003).
    • (2003) Adv. Drug Deliver. Rev. , vol.55 , pp. 1467
    • Foraker, A.B.1    Khantwal, C.M.2    Swaan, P.W.3
  • 243
    • 0035922104 scopus 로고    scopus 로고
    • Riboflavin carrier protein: A serum and tissue marker for breast carcinoma
    • A. A. Karande, L. Sridhar, K. S. Gopinath, and P. R. Adiga, Riboflavin carrier protein: A serum and tissue marker for breast carcinoma. Int. J. Cancer 95, 277 (2001).
    • (2001) Int. J. Cancer , vol.95 , pp. 277
    • Karande, A.A.1    Sridhar, L.2    Gopinath, K.S.3    Adiga, P.R.4
  • 244
    • 79957912157 scopus 로고    scopus 로고
    • FMN-coated fluorescent iron oxide nanoparticles for RCP-mediated targeting and labeling of metabolically active cancer and endothelial cells
    • J. Jayapaul, M. Hodenius, S. Arns, W. Lederle, T. Lammers, P. Comba, F. Kiessling, and J. Gaetjens, FMN-coated fluorescent iron oxide nanoparticles for RCP-mediated targeting and labeling of metabolically active cancer and endothelial cells. Biomaterials 32, 5863 (2011).
    • (2011) Biomaterials , vol.32 , pp. 5863
    • Jayapaul, J.1    Hodenius, M.2    Arns, S.3    Lederle, W.4    Lammers, T.5    Comba, P.6    Kiessling, F.7    Gaetjens, J.8
  • 246
    • 0032853242 scopus 로고    scopus 로고
    • In vitro selection of functional nucleic acids
    • D. S. Wilson and J. W. Szostak, In vitro selection of functional nucleic acids. Annu. Rev. Biochem. 68, 611 (1999).
    • (1999) Annu. Rev. Biochem. , vol.68 , pp. 611
    • Wilson, D.S.1    Szostak, J.W.2
  • 247
    • 0025194307 scopus 로고
    • Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA poly-merase
    • C. Tuerk and L. Gold, Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA poly-merase. Science 249, 505 (1990).
    • (1990) Science , vol.249 , pp. 505
    • Tuerk, C.1    Gold, L.2
  • 249
    • 84905643347 scopus 로고    scopus 로고
    • Progress in selection and biomedical applications of aptamers
    • Z. J. Xi, R. R. Huang, Y. Deng, and N. Y. He, Progress in selection and biomedical applications of aptamers. J. Biomed. Nanotechnol. 10, 3043 (2014).
    • (2014) J. Biomed. Nanotechnol. , vol.10 , pp. 3043
    • Xi, Z.J.1    Huang, R.R.2    Deng, Y.3    He, N.Y.4
  • 254
    • 0033543548 scopus 로고    scopus 로고
    • Antiproliferative activity of G-rich oligonucleotides correlates with protein binding
    • P. J. Bates, J. B. Kahlon, S. D. Thomas, J. O. Trent, and D. M. Miller, Antiproliferative activity of G-rich oligonucleotides correlates with protein binding. J. Biol. Chem. 274, 26369 (1999).
    • (1999) J. Biol. Chem. , vol.274 , pp. 26369
    • Bates, P.J.1    Kahlon, J.B.2    Thomas, S.D.3    Trent, J.O.4    Miller, D.M.5
  • 255
    • 67349167635 scopus 로고    scopus 로고
    • Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
    • P. J. Bates, D. A. Laber, D. M. Miller, S. D. Thomas, and J. O. Trent, Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer. Exp. Mol. Pathol. 86, 151 (2009).
    • (2009) Exp. Mol. Pathol. , vol.86 , pp. 151
    • Bates, P.J.1    Laber, D.A.2    Miller, D.M.3    Thomas, S.D.4    Trent, J.O.5
  • 256
    • 76749169748 scopus 로고    scopus 로고
    • AS-1411, a guanosine-rich oligonu-cleotide aptamer targeting nucleolin for the potential treatment of cancer, including acute myeloid leukemia
    • F. Mongelard and P. Bouvet, AS-1411, a guanosine-rich oligonu-cleotide aptamer targeting nucleolin for the potential treatment of cancer, including acute myeloid leukemia. Curr. Opin. Mol. Ther. 12, 107 (2010).
    • (2010) Curr. Opin. Mol. Ther. , vol.12 , pp. 107
    • Mongelard, F.1    Bouvet, P.2
  • 258
    • 0037099536 scopus 로고    scopus 로고
    • Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen
    • S. E. Lupold, B. J. Hicke, Y. Lin, and D. S. Coffey, Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res. 62, 4029 (2002).
    • (2002) Cancer Res. , vol.62 , pp. 4029
    • Lupold, S.E.1    Hicke, B.J.2    Lin, Y.3    Coffey, D.S.4
  • 259
    • 33845723241 scopus 로고    scopus 로고
    • An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform
    • V. Bagalkot, O. C. Farokhzad, R. Langer, and S. Jon, An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. Angew. Chem. Int. Ed. Engl. 45, 8149 (2006).
    • (2006) Angew. Chem. Int. Ed. Engl. , vol.45 , pp. 8149
    • Bagalkot, V.1    Farokhzad, O.C.2    Langer, R.3    Jon, S.4
  • 261
    • 7444223607 scopus 로고    scopus 로고
    • Nanoparticle-aptamer bioconjugates: A new approach for targeting prostate cancer cells
    • O. C. Farokhzad, S. Jon, A. Khademhosseini, T. N. Tran, D. A. Lavan, and R. Langer, Nanoparticle-aptamer bioconjugates: A new approach for targeting prostate cancer cells. Cancer Res. 64, 7668 (2004).
    • (2004) Cancer Res. , vol.64 , pp. 7668
    • Farokhzad, O.C.1    Jon, S.2    Khademhosseini, A.3    Tran, T.N.4    Lavan, D.A.5    Langer, R.6
  • 263
    • 75149193491 scopus 로고    scopus 로고
    • A nucleolin-targeted multimodal nanopar-ticle imaging probe for tracking cancer cells using an aptamer
    • W. Hwang do, H. Y. Ko, J. H. Lee, H. Kang, S. H. Ryu, I. C. Song, D. S. Lee, and S. Kim, A nucleolin-targeted multimodal nanopar-ticle imaging probe for tracking cancer cells using an aptamer. J. Nucl. Med. 51, 98 (2010).
    • (2010) J. Nucl. Med. , vol.51 , pp. 98
    • Hwang Do, W.1    Ko, H.Y.2    Lee, J.H.3    Kang, H.4    Ryu, S.H.5    Song, I.C.6    Lee, D.S.7    Kim, S.8
  • 264
    • 0028860660 scopus 로고
    • The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells
    • M. Derenzini, V. Sirri, D. Trere, and R. L. Ochs, The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. Lab. Invest. 73, 497 (1995).
    • (1995) Lab. Invest. , vol.73 , pp. 497
    • Derenzini, M.1    Sirri, V.2    Trere, D.3    Ochs, R.L.4
  • 265
    • 34250349188 scopus 로고    scopus 로고
    • Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?
    • P. Antunes, M. Ginj, H. Zhang, B. Waser, R. P. Baum, J. C. Reubi, and H. Maecke, Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?. Eur. J. Nucl. Med. Mol. I. 34, 982 (2007).
    • (2007) Eur. J. Nucl. Med. Mol. I. , vol.34 , pp. 982
    • Antunes, P.1    Ginj, M.2    Zhang, H.3    Waser, B.4    Baum, R.P.5    Reubi, J.C.6    Maecke, H.7
  • 268
    • 51049098968 scopus 로고    scopus 로고
    • Anticancer therapeutics: Targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor
    • V. M. Platt and F. C. Szoka, Jr., Anticancer therapeutics: Targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor. Mol. Pharm. 5, 474 (2008).
    • (2008) Mol. Pharm. , vol.5 , pp. 474
    • Platt, V.M.1    Szoka, F.C.2
  • 270
    • 77955276381 scopus 로고    scopus 로고
    • Core-shell hybrid nanogels for integration of optical temperature-sensing, targeted tumor cell imaging, and combined chemo-photothermal treatment
    • W. Wu, J. Shen, P. Banerjee, and S. Zhou, Core-shell hybrid nanogels for integration of optical temperature-sensing, targeted tumor cell imaging, and combined chemo-photothermal treatment. Biomaterials 31, 7555 (2010).
    • (2010) Biomaterials , vol.31 , pp. 7555
    • Wu, W.1    Shen, J.2    Banerjee, P.3    Zhou, S.4
  • 271
    • 84904904358 scopus 로고    scopus 로고
    • Nanoparticle enhanced optical imaging and phototherapy of cancer
    • A. M. Pekkanen, M. R. DeWitt, and M. N. Rylander, Nanoparticle enhanced optical imaging and phototherapy of cancer. J. Biomed. Nanotechnol. 10, 1677 (2014).
    • (2014) J. Biomed. Nanotechnol. , vol.10 , pp. 1677
    • Pekkanen, A.M.1    DeWitt, M.R.2    Rylander, M.N.3
  • 273
    • 84858615014 scopus 로고    scopus 로고
    • Iron oxide nanoparticles for targeted cancer imaging and diagnostics
    • J. E. Rosen, L. Chan, D. B. Shieh, and F. X. Gu, Iron oxide nanoparticles for targeted cancer imaging and diagnostics. Nanomedicine-UK. 8, 275 (2012).
    • (2012) Nanomedicine-UK. , vol.8 , pp. 275
    • Rosen, J.E.1    Chan, L.2    Shieh, D.B.3    Gu, F.X.4
  • 274
    • 80052893655 scopus 로고    scopus 로고
    • Medical applications of nanoparticles in biological imaging, cell labeling, antimicrobial agents, and anti-cancer nanodrugs
    • R. Singh and H. S. Nalwa, Medical applications of nanoparticles in biological imaging, cell labeling, antimicrobial agents, and anti-cancer nanodrugs. J. Biomed. Nanotechnol. 7, 489 (2011).
    • (2011) J. Biomed. Nanotechnol. , vol.7 , pp. 489
    • Singh, R.1    Nalwa, H.S.2
  • 277
    • 36048993546 scopus 로고    scopus 로고
    • Nanoplatforms for targeted molecular imaging in living subjects
    • W. B. Cai and X. Y. Chen, Nanoplatforms for targeted molecular imaging in living subjects. Small 3, 1840 (2007).
    • (2007) Small , vol.3 , pp. 1840
    • Cai, W.B.1    Chen, X.Y.2
  • 278
    • 67650573255 scopus 로고    scopus 로고
    • Polymeric nanomedicine for cancer MR imaging and drug delivery
    • C. Khemtong, C. W. Kessinger, and J. Gao, Polymeric nanomedicine for cancer MR imaging and drug delivery. Chem. Commun. 3497 (2009).
    • (2009) Chem. Commun. , vol.3497
    • Khemtong, C.1    Kessinger, C.W.2    Gao, J.3
  • 279
    • 30444441465 scopus 로고    scopus 로고
    • The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis
    • S. Gelperina, K. Kisich, M. D. Iseman, and L. Heifets, The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am. J. Resp. Crit. Care. 172, 1487 (2005).
    • (2005) Am. J. Resp. Crit. Care. , vol.172 , pp. 1487
    • Gelperina, S.1    Kisich, K.2    Iseman, M.D.3    Heifets, L.4
  • 280
    • 75149147998 scopus 로고    scopus 로고
    • Targeted delivery of low molecular drugs using chitosan and its derivatives
    • J. H. Park, G. Saravanakumar, K. Kim, and I. C. Kwon, Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv. Drug Deliver. Rev. 62, 28 (2010).
    • (2010) Adv. Drug Deliver. Rev. , vol.62 , pp. 28
    • Park, J.H.1    Saravanakumar, G.2    Kim, K.3    Kwon, I.C.4
  • 281
    • 84865513273 scopus 로고    scopus 로고
    • Theranostic applications of nanoparticles in cancer
    • N. Ahmed, H. Fessi, and A. Elaissari, Theranostic applications of nanoparticles in cancer. Drug Discov. Today 17, 928 (2012).
    • (2012) Drug Discov. Today , vol.17 , pp. 928
    • Ahmed, N.1    Fessi, H.2    Elaissari, A.3
  • 282
    • 80054821668 scopus 로고    scopus 로고
    • Theranostics: Combining imaging and therapy
    • S. S. Kelkar and T. M. Reineke, Theranostics: Combining imaging and therapy. Bioconjugate Chem. 22, 1879 (2011).
    • (2011) Bioconjugate Chem. , vol.22 , pp. 1879
    • Kelkar, S.S.1    Reineke, T.M.2
  • 284
    • 42049121123 scopus 로고    scopus 로고
    • Hydropho-bically modified glycol chitosan nanoparticles-encapsulated camp-tothecin enhance the drug stability and tumor targeting in cancer therapy
    • K. H. Min, K. Park, Y. S. Kim, S. M. Bae, S. Lee, H. G. Jo, R. W. Park, I. S. Kim, S. Y. Jeong, K. Kim, and I. C. Kwon, Hydropho-bically modified glycol chitosan nanoparticles-encapsulated camp-tothecin enhance the drug stability and tumor targeting in cancer therapy. J. Control Release 127, 208 (2008).
    • (2008) J. Control Release , vol.127 , pp. 208
    • Min, K.H.1    Park, K.2    Kim, Y.S.3    Bae, S.M.4    Lee, S.5    Jo, H.G.6    Park, R.W.7    Kim, I.S.8    Jeong, S.Y.9    Kim, K.10    Kwon, I.C.11
  • 285
    • 79956157382 scopus 로고    scopus 로고
    • Real-time and non-invasive optical imaging of tumor-targeting glycol chi-tosan nanoparticles in various tumor models
    • J. H. Na, H. Koo, S. Lee, K. H. Min, K. Park, H. Yoo, S. H. Lee, J. H. Park, I. C. Kwon, S. Y. Jeong, and K. Kim, Real-time and non-invasive optical imaging of tumor-targeting glycol chi-tosan nanoparticles in various tumor models. Biomaterials 32, 5252 (2011).
    • (2011) Biomaterials , vol.32 , pp. 5252
    • Na, J.H.1    Koo, H.2    Lee, S.3    Min, K.H.4    Park, K.5    Yoo, H.6    Lee, S.H.7    Park, J.H.8    Kwon, I.C.9    Jeong, S.Y.10    Kim, K.11
  • 287
    • 79251594875 scopus 로고    scopus 로고
    • Intracellularly monitoring/imaging the release of doxorubicin from pH-responsive nanoparticles using Forster resonance energy transfer
    • K. J. Chen, Y. L. Chiu, Y. M. Chen, Y. C. Ho, and H. W. Sung, Intracellularly monitoring/imaging the release of doxorubicin from pH-responsive nanoparticles using Forster resonance energy transfer. Biomaterials 32, 2586 (2011).
    • (2011) Biomaterials , vol.32 , pp. 2586
    • Chen, K.J.1    Chiu, Y.L.2    Chen, Y.M.3    Ho, Y.C.4    Sung, H.W.5
  • 288
    • 79951590463 scopus 로고    scopus 로고
    • Target-cancer-cell-specific acti-vatable fluorescence imaging probes: Rational design and in vivo applications
    • H. Kobayashi and P. L. Choyke, Target-cancer-cell-specific acti-vatable fluorescence imaging probes: Rational design and in vivo applications. Accounts Chem. Res. 44, 83 (2011).
    • (2011) Accounts Chem. Res. , vol.44 , pp. 83
    • Kobayashi, H.1    Choyke, P.L.2
  • 289
    • 81855227608 scopus 로고    scopus 로고
    • Intravital imaging
    • M. J. Pittet and R. Weissleder, Intravital imaging. Cell 147, 983 (2011).
    • (2011) Cell , vol.147 , pp. 983
    • Pittet, M.J.1    Weissleder, R.2
  • 290
    • 37749053190 scopus 로고    scopus 로고
    • Microscopic imaging techniques for drug discovery
    • A. Bullen, Microscopic imaging techniques for drug discovery. Nat. Rev. Drug Discov. 7, 54 (2008).
    • (2008) Nat. Rev. Drug Discov. , vol.7 , pp. 54
    • Bullen, A.1
  • 291
    • 79953028000 scopus 로고    scopus 로고
    • Intravital microscopy as a tool to study drug delivery in preclinical studies
    • P. Amornphimoltham, A. Masedunskas, and R. Weigert, Intravital microscopy as a tool to study drug delivery in preclinical studies. Adv. Drug Deliver. Rev. 63, 119 (2011).
    • (2011) Adv. Drug Deliver. Rev. , vol.63 , pp. 119
    • Amornphimoltham, P.1    Masedunskas, A.2    Weigert, R.3
  • 292
    • 47949096436 scopus 로고    scopus 로고
    • Contrast enhanced MRI and intravital fluorescence microscopy indicate improved tumor microcirculation in highly vascularized melanomas upon short-term anti-VEGFR treatment
    • M. E. Eichhorn, S. Strieth, S. Luedemann, A. Kleespies, U. Noth, A. Passon, G. Brix, K. W. Jauch, C. J. Bruns, and M. Dellian, Contrast enhanced MRI and intravital fluorescence microscopy indicate improved tumor microcirculation in highly vascularized melanomas upon short-term anti-VEGFR treatment. Cancer Biol. Ther. 7, 1006 (2008).
    • (2008) Cancer Biol. Ther. , vol.7 , pp. 1006
    • Eichhorn, M.E.1    Strieth, S.2    Luedemann, S.3    Kleespies, A.4    Noth, U.5    Passon, A.6    Brix, G.7    Jauch, K.W.8    Bruns, C.J.9    Dellian, M.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.